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The perinatal mortality rate has decreased in Scotland from 15.4 per 1000 total
births in 1978 to 8.7 per 1000 total births in 1989. This improvement is largely
accounted for by a decrease in mortality of infants weighing less than 1500g at
birth. It has become important to learn more about the nutrition of these infants
in an effort to decrease their mortality rate still further, to optimise their ability to
combat the diseases of prematurity, and to allow them to achieve their potential in
both growth and development.
Most infants weighing less than 1500g at birth are unable to establish full oral
feeds immediately. Total parenteral nutrition, transpyloric feedings or gastric
feedings must be given to provide the infant with adequate calories for growth and
development. This thesis contains a study in which very low birthweight infants
were randomly allocated to nasoduodenal or nasogastric routes of milk
administration. The nasoduodenal route proved to be more complex, more time-
consuming, and offered no advantages to the infants. Gastric feedings are
recommended as the best method of providing calories enterally to the very low
birthweight infant.
Rickets of prematurity continues to be described in the 1980's, involving diffuse
demineralisation of the skeleton and even bone fractures. Elevation of plasma
alkaline phosphatase activity is a commonly used biochemical marker of this
condition. Since large doses of vitamin D do not prevent the disease, it may be
that the problem is one of substrate deficiency. Included in this thesis is an
examination of the effects of adding extra calcium and then extra phosphorus to
the milk given to cohorts of very low birthweight infants. The addition of calcium
(0
alone reduced radiological evidence of rickets, while the addition of both calcium
and phosphorus maintained plasma alkaline phosphatase activity within normal
limits throughout the study period.
Magnesium is the second most abundant intracellular cation and is largely stored
in bone. Although supplements of calcium and phosphorus can be added to an
infant's milk such that the intrauterine accretion rates of these minerals can be
achieved postnatally, it is not known how magnesium, phosphorus and calcium
affect each other during absorption and subsequent metabolism. The
interrelationship of these three elements was examined using three day balance
studies, and this work provided a recommended magnesium concentration in milk
which may allow optimal intestinal absorption of both calcium and phosphorus in
the very low birthweight infant.
(ii)
This thesis was composed by myself and the results described herein are the
product of my own work.
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One of the most dramatic medical advances of the twentieth century has been the
decrease in infant mortality from over 100 per 1000 live births in the year 1900, to
around 11 per 1000 live births in 1984 in the United States of America (Avery &
Als, 1989). This remarkable change is still reflected in Scotland in recent years
where, from 1978 to 1989, the perinatal mortality rate has decreased from 15.4 to
8.7 per 1000 total births (Scottish Stillbirth and Neonatal Death Report, 1989).
The very low birthweight infant is defined as a newborn weighing less than 1500g at
birth. A subgroup of extremely low birthweight infants, weighing less than lOOOg at
birth may be identified. In 1989 the birthweight specific mortality of infants
weighing 1000-1499g at birth was 211.6 per 1000, and for those under lOOOg at birth
was 588.7 per 1000 total births: both of these figures show an increased survival
over previous years (Scottish Stillbirth and Neonatal Death Report, 1989).
Improved survival of the very low birthweight infant has been due partly to
increased understanding of techniques of artificial ventilation, and partly to
improved knowledge of the nutritional requirements of prematurity.
Neonatologists aim to provide a calorie intake for the preterm infant which will
produce a growth rate comparable to that of the fetus in utero at a similar
gestation. Studies of fetal growth depend principally on anthropometric
measurements of newborn infants born at differing gestational ages (Lubchenko et
al, 1963; Usher & McLean, 1969). It can be argued however that prematurity is an
abnormal physiological state, and that growth based on fetal data is not necessarily
ideal (Ounsted & Ounsted, 1973). Furthermore, such data is cross-sectional, but
longitudinal data of fetal growth is also now available by sequential ultrasound
measurements (Meire, 1981), and these follow closely the information obtained by
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anthropometric methods (Brook, 1982). Ultrasound measurements show that the
fetal crown-rump length grows exponentially from 6 to 14 weeks gestation (Meire,
1981), and there is a decrease in growth rate as measured by biparietal diameter in
the third trimester of pregnancy (Campbell & Newman, 1971; Meire, 1981).
Estimates of fetal volume can also be derived from linear measurements of
biparietal diameter and abdominal circumference, and the resultant assessments
of total fetal weight correspond well to the previous anthropometric standards
(Meire, 1981). These data show that fetal head growth velocity increases from 13
to 28 weeks, and then growth rate slows after 32 weeks gestation. Studies of
preterm infants show maximum head growth at 30 to 32 weeks gestation, and
thereafter a decline similar to the fetal pattern (Lubchenko et al, 1966; Usher &
McLean, 1969; Fujimura & Seryu, 1977). Increase in crown-heel length and weight
gain during the third trimester of pregnancy are most rapid between 31 and 36
weeks gestation (Lubchenko et al, 1963; Usher & McLean, 1969; Davies, 1981),
with a slower rate of growth until delivery at full term (Tanner, 1978).
Embryonic and fetal growth are influenced by intrinsic genetic potential, the
intrauterine environment, and maternal factors. Examples of abnormal fetal
growth may occur because of congenital malformations, chromosomal anomalies,
and intrauterine infections. Data from ultrasound measurements have shown two
patterns of poor fetal growth (Campbell, 1974). There may be early reduction in
abdominal circumference with a relative preservation of head growth velocity, and
this is considered often to be secondary to placental insufficiency particularly of
the third trimester. The second pattern is of symmetrical growth retardation of
both parameters, perhaps due to congenital malformation or early intrauterine
infection. Fetal growth may be adversely affected by the immediate intrauterine
environment, including an abnormal uterus, the presence of large uterine fibroids,
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or the occurrence of placenta praevia. Inadequate maternal diet can also affect
fetal growth (Thomson & Billewicz, 1957; Pitkin et al, 1972), and chronic maternal
disease or factors which affect placental transport such as pre-eclampsia may
interfere with fetal nutrition (Smith, 1947; Ounsted & Ounsted, 1966). Maternal
vitamin D deficiency is an example of a specific dietary lack which may also result
in intrauterine growth retardation (Moncrieff & Fadahunsi, 1974).
The fetus is fed transplacental^ by the umbilical vessels, the umbilical vein
providing input of fluid and nutrition, as well as supplying gases required for
complete fetal metabolism, while the umbilical arteries return waste products to
the placenta for elimination via the maternal blood stream. Most of human body
weight consists of water (Friis-Hansen, 1971) and this is exchanged across the
placenta and amniotic membranes (Plentl, 1959). Carbohydrate is provided by
transport of glucose from the maternal circulation (Shelley, 1979). Although a few
small proteins including the IgG gamma globulins can cross the placenta (Dancis
et al, 1961), the principal nitrogen sources are amino-acids, which are probably
actively transported across the placenta (Prenton & Young, 1969). Lipid transport
is largely restricted to a small number of fatty acids (Dancis & Schneider, 1978).
Nevertheless the percentage of body weight consisting of fat increases from 3.5%
at 28 weeks gestation to 15% at full term (Widdowson, 1981), probably due to de
novo synthesis (Dancis & Schneider, 1978).
Large quantities of sodium are transported across the placenta to the fetus during
the third trimester (Flexner et al, 1948; Cox & Chalmers, 1953). Active transport
mechanisms also exist in the placenta for transfer of calcium (Tsang et al, 1973;
Whitsett & Tsang, 1980) and phosphorus (Economou-Mavrou & McCance, 1958;
Khattab & Forfar, 1971). Placental transport of trace elements has been harder to
study. Fetal plasma zinc levels are higher than maternal concentrations, and
newborn preterm infants have higher values than infants at term (Berfenstam,
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1952), but the mechanism of transfer is unclear. Total fetal body copper increases
with advancing gestation (Widdowson et al, 1972), but again details of the transfer
from mother to fetus are unknown. Of the fat-soluble vitamins, Vitamin K1 does
not readily cross the placenta (Shearer et al, 1982), but Vitamin A (Wolff, 1932;
Lewis et al, 1943) and Vitamin D (Hillman & Haddad, 1974) do transfer in
significant quantities.
After a normal delivery at full term a healthy infant may lose 10% of body weight,
and most of this weight loss is attributable to loss of body water. Towards the end
of the first week the infant will then begin to grow, increasing in body weight
initially by 150 to 200g per week. Human breast milk can provide enough calories
for the healthy infant to provide for this period of rapid growth (Burman, 1982).
Breast milk contains approximately 65 kcal per 100ml of milk, although there is
considerable variation in its composition with time and between individuals
(Hytten, 1954; Hibberd et al, 1982). Proprietary milk formulas, with similar
calorie content, have been developed as a substitute for human breast milk.
In the 1930's most milk formulas were based on evaporated cow's milk with added
carbohydrate (Anderson et al, 1982). Formulas based on cow's milk had a higher
protein and sodium content than human breast milk (Department of Health and
Social Security, 1974). Cow's milk protein is high in casein which forms insoluble
curds in the high acidity of the human stomach (Avery & Fletcher, 1981), whereas
human breast milk protein has a high whey content which is readily digested.
Infants fed a whey predominant formula grow better than those given feedings
higher in casein (Berger et al, 1979). The high sodium content of unmodified cow's
milk can result in progressive hypernatraemia, and infants fed such formulas may
develop neurological sequelae (Finberg & Harrison, 1955; Macauley & Watson,
1967). Furthermore the renal capacity for excreting urea may be challenged, and
4
infants fed on cow's milk have higher plasma urea concentrations than those
infants fed on human breast milk (Davies & Saunders, 1973). Bakwin (1937)
described the association of feeding infants on cow's milk formulas and the
development of hypocalcaemic tetany. Cow's milk formulas have higher
concentrations of both calcium and phosphorus, and the high phosphate load
appears to cause symptomatic hypocalcaemia (Gittleman & Pincus, 1951; Gardner,
1952).
In the 1970's low solute cow's milk formulas were introduced, and the currently
available artificial milks now have a lower content of sodium and protein than
unmodified cow's milk (Department of Health and Social Security, 1980). Cow's
milk fat is less well absorbed than breast milk fats (Widdowson, 1981) and has
therefore been partially or totally replaced by more digestible fatty acids. A
whey:casein ratio resembling human breast milk is also adopted in some highly
modified proprietary milks. Clinical studies of infants fed low solute milks have
shown a reduction in hypocalcaemia (Oppe & Redstone, 1968; Barltrop & Hillier,
1974) and decreased hypernatraemia (Arneil & Chin, 1979; Manuel & Walker-
Smith, 1980).
In the early 1950's it was suggested that low birthweight infants should be deprived
of food in the first few days of postnatal life (Gaisford & Schofield, 1950; Hansen
& Smith, 1953), but a decade later it was recognised that this strategy might result
in cerebral palsy and mental retardation (Davies, 1978). The very low birthweight
infant requires a protein and calorie intake sufficient to sustain growth and brain
development (Winick & Rosso, 1969; Dobbing, 1981). Inadequate growth of the
preterm infant has subsequent adverse implications in terms of growth (Drillien,
1964; Shaw, 1973; Dobbing, 1981) and development (Drillien, 1964; Lubchenko et
al, 1972; Dobbing, 1981). The human brain grows rapidly from the second
trimester of pregnancy to the second year of postnatal life (Dobbing & Sands, 1973;
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Dobbing, 1981), during which time there is an urgent need for calories and
especially for large quantities of fatty acids (Clandinin et al, 1980; Cockburn et al,
1981). The developing brain is highly susceptible to malnutrition at this time, the
vulnerability being closely linked with the stage of development (Dobbing, 1981).
A low initial intake of calories may affect the brain of the low birthweight infant
resulting in neurological disturbance, including learning difficulties and a
decreased intelligence quotient (Drillien, 1964; Lubchenko et al, 1972).
Detailed studies of nutrition may include assessment of adequacy of intake,
gastrointestinal absorption, metabolic effects and change in weight and body size
(Reimer et al, 1980; McLaren, 1982). Measuring growth is crucial in assessing the
adequacy of nutrition in the newborn period (Davies, 1981). Weight, length
(either crown-rump, or crown-heel or both) and head circumference are the most
frequently used. Weight is often reliably and reproducibly measured, but fluid
overload can produce overestimates of true nutritional body weight (Brans et al,
1976). Lean body mass and total body fat are alternative means of assessing
nutritional status (James, 1981). Body fat can be estimated by measuring skinfold
thickness (Edwards et al, 1955), and upper arm muscle circumference can be
measured as an indicator of total body protein (James, 1981). Reference standards
have been compiled for body weight, length and head circumference (Lubchenko
et al, 1963, 1966; Usher & McLean, 1969; Babson et al, 1970; Tanner & Thomson,
1970; Gairdner & Pearson, 1971; Kitchen et al, 1981). It is recommended that the
standard selected should be that most suitable for the individual in terms of race,
sex, socioeconomic status and geographical position (Davies, 1981).
Energy requirements of the newborn depend on weight (Sinclair et al, 1967),
growth rate (Brooke et al, 1979; Chessex et al, 1981), calorie intake (Bhakoo &
Scopes, 1974), thermal environment (Glass et al, 1969, 1975; Davies & Davis,
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1970) and activity (Brooke et al, 1979). Calorie intake is also dependent on the
degree of digestion and absorption of nutrients, especially fats (Sinclair et al,
1980). It is recognised that the preterm infant absorbs fat less well than the
neonate at full term (Koldovsky, 1978). It has also been observed that human milk
fat and vegetable fat are absorbed better than butter fat (Shaw, 1976). Nutritional
intake provides calories for maintenance energy as well as for growth. The mean
maintenance energy requirement of the preterm infant has been estimated at
64kcal/kg/day, and the metabolisable energy intake required to provide this
maintenance is 83.5kcal/kg/day (Brooke et al, 1979).
The American Academy of Pediatrics Committee on Nutrition (1977)
recommended that formulas for the low birthweight infant should contain 40-50%
of the calorie content as fat. Protein for the enterally fed preterm infant should
provide 2.5-5g/kg body weight/day (Barness, 1975; American Academy of
Pediatrics Committee on Nutrition 1977; Burman, 1982). A dietary intake of
protein less than 2g/kg/day is associated with decreased weight gain (Davidson et
al, 1967; Babson & Bramhall, 1969). A protein intake greater than 6g/kg/day can
produce an elevated plasma urea (Davidson et al, 1967) and metabolic acidosis
(Barness, 1975). Dietary carbohydrate is generally in the form of lactose, and
provides a source for the monosaccharides, glucose, and galactose. Enteral feeds
must also supply adequate amounts of electrolytes, minerals and vitamins.
Adequate nutrition of the preterm infant is important for intact survival, yet the
choice of feeds and the technique of administering them are both limited by
immaturity of the organs, particularly the renal, gastrointestinal and central
nervous systems. Immaturity of kidney function (Arant, 1978) including a
restricted ability to excrete a water load (Ames, 1953) limit the volume of feed that
a preterm infant may tolerate. The gastrointestinal tract of the preterm infant is
immature, and calorie intake is restricted because of decreased absorption of fats
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as compared to full term infants (Sinclair et al, 1980). Carbohydrate absorption is
also restricted, and intestinal lactase activity begins to increase only after 30 weeks
gestation (Grand et al, 1979). Preterm infants tend to develop a suck and swallow
reflex at 33 to 34 weeks gestation (Grybowski, 1965, 1969) and must be able to
defend their airways against inhalation of milk before breast or bottle feeding can
be safely adopted.
Early techniques of feeding the preterm infant were by rubber-nozzled dropper,
but an indwelling nasogastric tube was first recommended in the early 1950's
(Royce et al, 1951). Nasogastric feeding fell temporarily out of favour because of
the reported hazards of milk aspiration (Wharton & Bower, 1965) and
exacerbation of respiratory distress (Yu, 1976). It was suggested (Valman et al,
1972) that these problems might be minimised by continuous infusion of milk
rather than giving the feeds by intermittent bolus (Yu, 1976; Pitcher-Wilmott et al,
1979). Transpyloric feedings (Hyde, 1978) may avoid some of the problems of the
nasogastric route, but complications of this method have also been reported,
including intestinal perforation (Boros & Reynolds, 1974; Loo et al, 1974; Chen &
Wong, 1974), pyloric stenosis (Evans, 1982; Raine et al, 1982), malabsorption (Roy
et al, 1977), poor growth (Whitfield, 1982) and necrotising enterocolitis (Heird,
1973; Beddis & McKenzie, 1979; Dryburgh, 1980).
The development of total parenteral nutrition provided an alternative to the
enteral route of feeding the preterm infant. The effectiveness of intravenous
sources of nitrogen and fat (Shenkin & Wretlind, 1978) led eventually to
the development of total parenteral nutrition for the term and preterm infants
(Wilmore & Dudrick, 1968; Heird et al, 1972; Peden & Karpel, 1972). Early
problems occurred with hyperammonaemia (Johnson et al, 1972; Cockburn, 1976)
until a crystalline amino-acid preparation became available. The advent of a safe
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preparation of fat (Cohen et al, 1977) allowed lower glucose concentrations to be
used. Nevertheless metabolic disturbances may still occur with total parenteral
nutrition in preterm infants (Shaw, 1973) unless constant vigilance is used (Yu et
al, 1979).
Total parenteral nutrition may be administered by catheter into either a central or
a peripheral vein. Insertion into a central vein may cause perforation of the vein
and, in the case of attempted internal jugular vein cannulation, a pneumothorax
(Shenkin & Wretlind, 1978). Extravasation of fluid from a peripheral vein
may cause extensive tissue destruction (Heird & Driscoll, 1975) including
permanent cosmetic defects to the surrounding skin. Fasting in adult mammals
may be associated with flattening of intestinal villi and mucosal atrophy (Feldman,
1974). Furthermore intraluminal nutrition stimulates the release of local intestinal
hormones which may enhance enterocyte growth and stimulate bile flow (Aynsley-
Green, 1983). Total parenteral nutrition by contrast may result in cholestasis
(Sondheimer et al, 1978). Acquired infection, bacterial or fungal, may also
complicate the use of total parenteral nutrition in the neonate (Driscoll et al, 1972;
Bryan et al, 1973; Shaw, 1973; Glass et al, 1984). Sterile techniques can minimise
this last hazard (Sanders & Sheldon, 1976). While the process is complex, time-
consuming and requires constant attention to plasma biochemical measurements,
the use of total parenteral nutrition may allow a higher calorie intake than the
enteral routes provide (Hume et al, 1981). A prospective randomised trial of very
low birthweight infants has subsequently shown that the early introduction of
enteral feedings can reduce both cholestasis and osteopenia of prematurity (Dunn
et al 1988). Supplementing enteral nutrition with parenteral nutrition is also a
possible option (Benda & Babson, 1971; Bryan et al, 1973; Pildes et al, 1973; Brans
et al, 1974; Abitbol et al, 1975; Cashore et al, 1975). Greater nitrogen and calorie
intake, with consequent improved weight gain may occur (Gunn et al, 1978; Yu et
al, 1979).
9
Concern about aspiration of milk into the respiratory tract during nasogastric
feeding of the preterm infant (Van Caillie & Powell, 1975) encouraged the use of
transpyloric routes of feeding, and both nasoduodenal and nasojejunal methods
have been used, but there is disagreement over which techniques produce better
growth rates and fewer complications (Roy et al, 1977; Pereira & Lemons, 1981;
Whitfield, 1982). In a large survey of neonatal intensive care units in the United
States it was established that 15% of the units used a transpyloric method of
delivering feeds to infants of birthweight less than lOOOg (Churella et al, 1985). In
those units which elect to feed very low birthweight infants directly into the
stomach, either nasogastric or orogastric methods may be chosen. Nasogastric
tubes can cause partial nasal obstruction with resultant increased airways
resistance and may therefore reduce ventilation (Stocks, 1980). Orogastric tubes
are however more difficult to secure because of mobility of the cheeks and tongue,
but this problem may be solved by the use of a palatal appliance (Van Someren et
al, 1984) although not all neonatal units have ready access to an orthodontist to
fashion and refashion the required fixation method as the infant grows. With
gavage feeding there still remains the further choice of frequency of feeds,
including the use of continuous pump, intermittent pump, intermittent bolus and
continuous gravity drip. There is still lack of uniformity between units (Churella et
al, 1985), with clinicians responding to the perceived needs of individual infants
but without significant data to direct a logical choice.
The nutritional requirements of the preterm infant differ from that of the term
infant. For normal growth and development to occur it is considered desirable to
achieve intrauterine accretion rates of nutrients, although immaturity of the
gastrointestinal and renal systems may put limits on this principle. The fatty acid
composition of feeds for the low birthweight infant is critical, because the last
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trimester of pregnancy is a period of rapid brain growth, and there is a large
accretion rate of long-chain unsaturated products including arachidonic acid and
docosahexaenoic acids (Clandinin et al, 1980). After birth at term however, the
main fatty acid requirement is for long-chain saturated and mono-unsaturated fatty
acids (Cockburn et al, 1981). The preterm infant may therefore require a feed
which differs in fat composition from that which is ideal for the mature neonate.
High intakes of protein may result in an increase in linear growth and a greater
rate of increase of head circumference (Brooke et al, 1982). Amino-acid
composition of the milk must also be considered since the preterm infant requires
some amino-acids which are not needed by the infant at term. There is decreased
hepatic cystathionase activity in fetuses and preterm infants (Sturman et al, 1970;
Gaull et al, 1972), and this is consistent with the observation that preterm infants
fail to show an elevation of plasma cystine levels after a methionine load.
Furthermore removal of cystine from the diet results in impaired nitrogen
retention and poor growth of the preterm infant (Snyderman, 1971).
The quantities of calcium and phosphorus available in human milk are insufficient
to match intrauterine accretion rates of these minerals from 28 to 40 weeks
gestation (Widdowson, 1981). Dietary deficiencies can be made worse by
incomplete gastrointestinal absorption of calcium (Shaw, 1976), zinc (Dauncey et
al, 1977), and fat (Koldovsky, 1978).
There are potential immunological and nutritional advantages in the use of breast
milk (Ogra & Greene, 1982), but human breast milk may not be ideal for the
preterm infant (Davies, 1977; Fomon et al, 1977; Davies and Evans, 1978; Tyson et
al, 1981). While expressed breast milk may have a calorie content of
approximately 65kcal/100ml, drip breast milk, obtained from the contralateral
breast during feeding, has a low fat and energy content. Pools of donor breast milk
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may have energy contents as low as 45kcal/100ml which is inadequate for the
metabolic demands and normal growth of the preterm infant (Gibbs et al, 1978;
Lucas et al, 1978).
Breast milk of a mother who has delivered an infant at term (mature human milk)
differs from that of a mother whose infant has been born prematurely (preterm
human milk). Preterm milk has a higher concentration of total nitrogen (Atkinson
et al, 1978), sodium, chloride, magnesium and iron (Lemons et al, 1982), copper
and zinc (Atinmo & Omolulu, 1982) although the importance of each of these
differences is not established. Inadequate calcium and phosphate intake have
been associated with rickets of prematurity (Day et al, 1975; Rowe et al, 1979;
Steichen et al, 1980). Hyponatraemia was recorded in preterm infants fed
unsupplemented human milk (Day et al, 1976; Roy et al, 1976). Artificial formulas
are now being developed for the preterm infant to counteract the inadequacies of
human breast milk and standard low solute formulas. These highly modified
formulas vary in detail, and especially in the types of fat and carbohydrate
employed. In some formulas up to 40% of the fat is in the form of medium chain
triglycerides, and this may spare dietary nitrogen and enhance calcium and
magnesium absorption (Tantibhedyangkul & Hashim, 1978). However a diet high
in medium chain triglycerides may not produce faster growth of infants, and has
been shown to predispose to abdominal distension, loose stools, vomiting and
increased gastric aspirates (Okamoto et al, 1982). Lactose, maltodextrin and
glucose are frequently used as carbohydrate sources in these highly modified milks.
Lactose enhances absorption of calcium and magnesium from the gut, but
excessive intakes may result in diarrhoea and metabolic acidosis (Auricchio et al,
1965). The combined use of lactose and glucose polymers provides sufficient
carbohydrate while avoiding the problems of an excessive solute load.
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Milk formulas specially modified for low birthweight infants also address some of
the deficiencies of human breast milk when fed to the preterm infant: extra
sodium, up to 45mg/100ml in Osterprem (Farley Health Products), calcium, up to
lOOmg/lOOml in Nenatal (Cow & Gate), and phosphorus, up to 56mg/100ml in
Similac 24 LBW (Ross Abbott). Amounts of magnesium contained in these
adapted formulas vary from 3mg/100ml in Osterprem (Farley Health Products) to
15mg/100ml in Nenatal (Cow & Gate). Quantities of trace elements and vitamins
incorporated in these formulas are also very variable, reflecting a lack of data on
ideal amounts. Clinical trials show that such highly modified milk formulas may
have some measurable benefits over human breast milk when fed to the preterm
infant, including faster weight gain, more rapid increase in head size and length,
and a decreased incidence of hyponatraemia and osteopenia of prematurity
(Brooke et al, 1982; Gross, 1983; Lucas et al, 1984).
Many important uncertainties remain, however, and the following studies were
designed to investigate further the most appropriate method of feeding low
birthweight infants. Preterm neonates of birthweight between 750 and 1499g were
chosen in order to examine a group likely to survive and yet who provide most
problems in terms of nutrition. Subsequent to these studies survival of infants
weighing 500 to 749g at birth has become more common, and further work will
require to be done to identify the requirements of this new cohort.
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CHAPTER 2
A COMPARISON BETWEEN NASOGASTRIC AND NASODUODENAL
METHODS OF FEEDING THE VERY LOW BIRTHWEIGHT INFANT
Introduction
The healthy infant delivered at full term can establish a caloric intake sufficient for
normal growth within a few days of delivery (Burman, 1982), and this is
accomplished by oral intake from breast or bottle feeds. In most preterm infants
however the ability to root, suck, swallow and defend the airway against milk
inhalation is not developed until 33 to 34 weeks gestation (Grybowski, 1965, 1969),
and therefore oral intake of feeds is initially inadvisable (Roberton, 1979; Burman,
1982). Furthermore neonatal gastric motility may be low (Roberton, 1979) and
gastric emptying has been considered to be delayed in sick premature infants
(Heird & Driscoll, 1975; Roberton, 1979). Four principal methods have therefore
been adopted to feed the preterm infant until sufficient maturity of the central
nervous system allows oral feeding to become the sole method of nutritional
intake. These techniques are total parenteral nutrition, supplemental parenteral
nutrition, transpyloric nutrition and gavage feeding.
Total parenteral nutrition has been shown to be a feasible technique in full term
infants (Wilmore & Dudrick, 1968) and in preterm infants (Peden & Karpel, 1972;
Heird et al, 1972). In the preterm infant respiratory illness may increase metabolic
demands and also limit the possibility of achieving high caloric intake by enteral
feeds. In early studies intravenous glucose infusions to preterm infants were shown
to improve survival (Cornblath et al, 1966). Nevertheless renal function is
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immature in these preterm infants, and this may limit the delivery of large fluid
volumes (Arant, 1978) because of a decreased ability to excrete a water load in the
first week of life (Ames, 1953).
It has also been claimed that a high fluid intake might predispose to necrotising
enterocolitis and symptomatic persistence of the ductus arteriosus (Bell et al,
1980). It has been observed that total parenteral nutrition provides a higher
caloric intake than the same volume of enteral feeding (Hume et al, 1981).
Whereas with enteral feeds infants require 110-150kcal/kg/day for adequate
growth (American Academy of Pediatric Committee on Nutrition, 1977; Burman,
1982), parenteral nutrition can achieve satisfactory growth with a parenteral intake
of only 60-88kcal/kg/day (Coran, 1973; Anderson et al, 1979).
Total parenteral nutrition consists of an infusion of glucose, a protein hydrolysate
or crystalline amino-acids, a fat emulsion, and a mixture of minerals, electrolytes
and vitamins. The main carbohydrate source is glucose, often at a concentration of
10% but rising to as much as 50% in the face of hypoglycaemia, or if additional
calories are required for growth. Careful monitoring of plasma glucose levels is
required to guard against osmotic diuresis in the preterm infant resulting in fluid
and electrolyte losses (Stonestreet et al, 1980). A source of nitrogen intake is also
essential for normal growth (Cockburn, 1976) and in preterm infants this has been
adequately achieved by an intake of 0.43-0.56g protein/kg/day (Zlotkin et al,
1981). Early attempts to produce nitrogen sources in parenteral nutrition were in
the form of small peptides which produced hydrolysates with a high ammonia
content (Hume et al, 1981).
Although the development of crystalline amino-acid solutions improved this
problem, amino-acid solutions continued to create acidaemia, osmotic diuresis and
elevated plasma ammonia levels (Hume et al, 1981). A recommended amino acid
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intake for the preterm infant is 2.5g/kg/day (Grotte et al, 1982). Fat provides
much of the energy intake of the preterm infant, and there are now emulsified
isotonic preparations of vegetable oil in water available for intravenous use. These
preparations are high in caloric content and also provide essential fatty acids for
the infants (Cockburn, 1977). Intralipid, the form used routinely in our clinical
practice, is a commercially available fat emulsion which appears to be safe for use
in preterm infants (Cohen et al, 1977). Preterm infants show decreased clearance
of fat from plasma (Andrew et al, 1976; Shennan et al, 1977). If the rate of lipid
clearance falls behind the rate of lipid infused, then the elevated plasma lipid
content could alter pulmonary function (Friedman et al, 1978) with accumulation
of fat in pulmonary capillaries (Levene et al, 1980) and fat deposition in
macrophages (Koga et al, 1975; Passwell et al, 1976). One regimen recommends
that preterm infants be given quantities of fat up to 2g/kg/day during the first few
days of life (Grotte et al, 1982) and 3-4g/kg/day thereafter (Kerner & Sunshine,
1979; American Academy of Pediatrics Committee on Nutrition, 1981; Grotte et
al, 1982). During intravenous lipid administration triglyceride levels should be
monitored and plasma turbidity assessed by visual inspection (Kerner & Sunshine,
1979; Grotte et al, 1982), with particular care being taken in the presence of
bacterial infection, pulmonary disease and hyperbilirubinaemia.
Parenteral nutrition may be administered through a central venous or umbilical
arterial catheter (Driscoll et al, 1972; Peden & Karpel, 1972; Heird & Driscoll,
1975; McMahon et al, 1975; Hall & Rhodes, 1976) or via a peripheral vein (Benda
& Babson, 1971; Coran, 1973; Heird & Driscoll, 1975). Central catheters allow the
infusion of solutions of high osmolality (Grotte et al, 1982) and may remain in
position for many weeks if necessary. Catheter related problems include bacterial
and fungal infection (Driscoll et al, 1972; Bryan et al, 1973; Brans et al, 1974) but
the incidence of these problems may be lessened by careful attention to sterile
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technique (Sanders & Sheldon, 1976). Other complications of central catheters
include pneumothorax, intrapleural infusion, catheter displacement and vessel
perforation (Shenkin & Wretlind, 1978). It is often quicker, simpler and less
stressful for the infant when a peripheral site is selected, but highly osmolar
solutions have a sclerosing effect on the smaller peripheral veins, and
extravasation of infusate causes tissue damage (Heird & Driscoll, 1975) with
consequent significant cosmetic defects of the skin. Parenteral nutrition has also
been associated with hyperglycaemia (Dweck & Cassady, 1974), metabolic acidosis
(Driscoll et al, 1972; Brans et al, 1974), hyperammonaemia (Johnson et al, 1972)
and hepatic dysfunction (Touloukian & Seashore, 1975; Sondheimer et al, 1978;
Postuma & Trevenen, 1979; Viliesis et al, 1980). Furthermore it is essential to
monitor biochemical parameters, and to keep vigilant clinically and
bacteriologically in order to identify problems early (Kerner & Sunshine, 1979;
Reimer et al, 1980; Grotte et al, 1982).
Parenteral nutrition may also be used to supplement enteral intake in preterm
infants (Benda & Babson, 1971; Cashore et al, 1975). Intravenous glucose is a
commonly used adjunct (Heird & Driscoll, 1975). Intravenous solutions have been
given to infants in order to decrease the volume of nasogastric intake, in the hope
of reducing the risk of milk inhalation (Bryan et al, 1973; Pildes et al, 1973;
Cashore et al, 1975). With this combined feeding approach it is possible to achieve
increases in weight, length and occipitofrontal circumference comparable to
intrauterine growth rates (Cashore et al, 1975).
Detailed studies have been undertaken to assess the value of total parenteral
nutrition and supplemental parenteral nutrition (Bryan et al, 1973; Pildes et al,
1973; Brans et al, 1974; Abitbol et al, 1975; Gunn et al, 1978; Yu et al, 1979). The
studies of Bryan et al (1973) and Pildes et al (1973) both demonstrated rapid
weight gains with supplemental parenteral nutrition, although Brans et al (1974)
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considered that the improved weight gain was attributable to fluid retention since
there were no differences in length and skinfold thickness.
Few controlled studies have compared total parenteral nutrition with enteral
nutrition as methods of feeding neonates (Gunn et al, 1978; Yu et al, 1979; Glass
et al, 1984). In one study of 34 preterm infants, total parenteral nutrition over the
first two weeks of life was compared to the use of intermittent nasogastric feeding
supplemented with intravenous glucose electrolyte as necessary (Yu et al, 1979),
and demonstrated better weight gain in the parenteral group along with a lower
occurrence of necrotising enterocolitis. By contrast Glass et al (1984) showed an
unacceptably high incidence of sepsis with total parenteral nutrition, whether
administered by central or peripheral catheters, and concluded that the
transpyloric route of feeding preterm infants may be safer.
Nasogastric feeding is the simplest of the methods of enteral feeding of preterm
neonates. The nasogastric route may however exacerbate respiratory distress (Yu,
1976) or result in aspiration pneumonia (Wharton & Bower, 1965). In preterm
infants with established respiratory distress enteral feeding may produce an
increase in respiratory rate (Yu & Rolfe, 1976), a decrease in arterial oxygen
tension (Yu, 1976) and a decrease in functional residual capacity (Pitcher-Wilmott
et al, 1979). It has been pointed out that the reduction in arterial oxygen tension is
related to the volume of fluid administered nasogastrically (Yu, 1976), and giving
milk by continuous infusion or as small intermittent boluses may lessen the adverse
effects (Yu, 1976; Pitcher-Wilmott et al, 1979). A gastric tube may also provide
partial blockage to the upper airway, and a significant increase in airways
resistance has been identified in such infants (Stocks, 1980). Theoretically the use
of an orogastric tube might obviate this problem, but the mobility of cheeks and
tongue of the neonate have created difficulties in securing the feeding tube.
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Orogastric feeding may however be successfully accomplished without compromising
the nasal passages if an orthodontic appliance is made to provide palatal fixation
of the tube (Van Someren et al, 1984).
Transpyloric feeding does not answer the problem of upper airways resistance, and
indeed may exacerbate this problem since a nasogastric tube is generally also
inserted into the same nostril. Delivering milk beyond the pylorus may however
answer some of the potential respiratory problems associated with gastric feeding
particularly if gastro-oesophageal reflux were to predispose to milk aspiration.
Nasal insertion of a weighted silastic catheter enclosed in a firmer outer catheter
was pioneered by Rhea et al (1973). The use of a polyvinylchloride (PVC)
catheter, without an outer catheter, was subsequently described (Cheek & Staub,
1973). Concerns that the PVC catheters might cause intestinal perforation (Boros
& Reynolds, 1974; Chen & Wong, 1974; Loo et al, 1974) encouraged the use of
silastic catheters with a weighted end but no enclosing catheter (Hyde, 1978;
Beddis & McKenzie, 1979; Dryburgh, 1980). Although transpyloric feeding has
proved difficult in infants receiving intermittent positive pressure ventilation by
face mask (Wells & Zachman, 1975; Beddis & McKenzie, 1979), it has been
successfully used for infants ventilated via endotracheal tube (Dryburgh, 1980).
Although transpyloric feeding attracted early reports of complications including
intestinal perforation (Boros & Reynolds, 1974; Chen & Wong, 1974; Sun et al,
1975; Perez-Rodrigues et al, 1978), and intussusception (Chen & Wong, 1974), it is
considered that these problems were largely due to the use of PVC tubes which
harden after insertion (Boros & Reynolds, 1974), and such complications are
rarely described with the now favoured silastic tubes (Perez-Rodrigues, 1978).
More than 90% of infants who develop necrotising enterocolitis do so after enteral
feeds have been delivered (Kliegman, 1990), and since there is a strong association
between necrotising enterocolitis and prematurity (Ryder et al, 1980; Wilson et al,
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1982) it is not surprising that necrotising enterocolitis has been observed with both
nasogastric and transpyloric feedings (Goldman, 1980; Yu et al, 1979). Clark and
Miller (1990) hypothesize that intestinal injury may be initiated from the lumen,
perhaps with undigested components of feedings providing substrate for
pathogenic bacteria, but the role of transpyloric feeding in the aetiology of
necrotising enterocolitis has proved difficult to establish. Diarrhoea is a common
feature associated with transpyloric feeding (Van Caillie & Powell, 1975; Hyde,
1978; Dryburgh, 1980) and may occasionally be due to the tip of the tube passing
too far along the small intestine (Hyde, 1978). Fat malabsorption may be seen in
infants fed nasojejunally (Roy et al, 1977) but not in those fed nasoduodenally
(Van Caillie & Powell, 1975).
Several previous, and occasionally conflicting, studies have compared transpyloric
feeding with nasogastric feeding (Wells & Zachman, 1975; Van Caillie & Powell,
1975; Drew et al, 1979; Pereira & Lemons, 1981; Whitfield, 1982). In infants of
birthweight less than 1500g a better initial weight gain, associated with superior
fluid and caloric intake, has been shown when continuous nasojejunal feeding was
compared to intermittent nasogastric feeds (Wells & Zachman, 1975). Van Caillie
& Powell (1975) drew similar conclusions when comparing continuous
nasoduodenal feeding versus continuous nasogastric feeding in infants of
birthweight less than 1300g. In conflict with these studies is a comparison of
continuous nasoduodenal feeding with intermittent nasogastric feeding when
applied to infants of birthweight less than 1700g: Pereira & Lemons (1981) showed
no differences in caloric intake and growth after the fourth day of life.
Furthermore Drew et al (1979) also demonstrated no benefit to infants fed
nasojejunally compared to a similar group fed nasogastrically, while Whitfield
(1982) found a better growth velocity in the nasogastrically fed group compared to
the group fed nasoduodenally despite the caloric intakes being similar.
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Churella (1985) surveyed 269 neonatal intensive care units in the United States of
America to discover how low birthweight infants were being fed, and discovered
that most neonatal units gave parenteral feeds to infants of birthweight less than
lOOOg during the first week of life. The majority also gave a mixture of parenteral
and enteral nutrition to infants with birthweight between 1001 and 2499g. The first
enteral feeds to be given were generally by gastric tube, but in 15% of units, the
transpyloric route was selected as the method of choice (Churella et al, 1985).
Adequate caloric intake for the preterm infant, even in the first days of postnatal
life, is essential for survival, growth and normal development. Because of the
limitations of gastrointestinal maturity it has been doubted that this can be
achieved by the enteral route alone. Nevertheless a high occurrence of sepsis
associated with total parenteral nutrition persuaded Glass et al (1984) that enteral
feeding was the safer alternative. Because the passing of transpyloric tubes
involves stress to the infant, extra radiological exposure and is occasionally very
time-consuming, the following study attempted to examine the advantages and
disadvantages of gastric and transpyloric feeding for very low birthweight infants.
The study compares two groups of infants of birthweight less than 1500g. In one
group feeding was by nasogastric tube, while the other group was fed initially by
the nasoduodenal route.
Patients and Methods
Between September 1982 and February 1984 all infants of birthweight 750 to
1500g admitted to the Neonatal Intensive Care Unit, Simpson Memorial Maternity
Pavilion, Edinburgh, within 24 hours of birth were entered into the study. All 100
infants were allocated alternately to nasogastric or nasoduodenal feeding on a
rigidly observed basis uninfluenced by the clinical condition of the infant. On
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completion of the trial, infants appropriate for gestational age were selected from
both groups for comparison of outcome.
Fluid intake targets were the same. Soon after birth a peripheral intravenous
infusion was started based on a 9.5% dextrose cocktail with sodium content
20mmol/L (46mg/dL). No amino-acid nor lipid solutions were given. At three
hours a feeding tube was passed and, if positioned successfully, milk feeds began at
0.5ml/hour (for infants of birthweight less than lOOOg) or lml/hour (for infants
weighing between 1000 and 1500g at birth). Similarly, six-hourly increments of milk
intake were by 0.5ml/hour or lml/hour according to weight. Planned fluid
requirements in both nasogastric and nasoduodenal groups began at 50ml/kg/day
on day one, and increased daily by 25ml/kg/day to 150ml/kg/day. Decisions to
increase still further were taken thereafter on an individual clinical basis.
In the group fed nasogastrically a 5 gauge (Argyle) feeding tube was passed at
three hours and the position checked by acid reaction of the aspirate with litmus
paper. Hourly bolus feeds were given by syringe administration. In the group fed
transpylorically initial passage of a 5 FC silastic nasoduodenal tube (Vygon) was
attempted at three hours of life, and continuous feeding was begun when the tube
was in position, which was confirmed radiologically. The optimum tube end site
used was the second part of the duodenum. Primary failure of passage was defined
as inability to pass a tube through the pylorus on any occasion. In some infants,
previously intubated successfully, the tube became displaced: subsequent failure to
reposition the transpyloric tube was termed secondary failure. In both groups
intravenous dextrose electrolyte solution supplemented the infants' planned fluid
requirements until full enteral feeding was established. At 1600g both groups were
fed by intermittent hourly nasogastric feeding, progressing to two-hourly feeds at
1750g weight, three-hourly feeds at 1800g, and thereafter full bottle or breast
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feeding on an individual basis. Infants were weighed naked on admission and then
daily until discharge using an integrated electronic balance (Mettler 515). Crown-
rump and crown-heel lengths were measured weekly using a Harpenden
neonatometer, and occipitofrontal circumference was also documented on a
weekly basis. Mortality and number of outborn versus inborn infants were
compared by 2 x 4 contingency tables. All other statistical analysis was by Student's
t test. Permission to carry out the study was obtained from the Reproductive
Medicine Ethical Subcommittee, Simpson Memorial Maternity Pavilion.
Results
Of the 50 infants allocated to the primarily nasogastric regimen, 35 were
appropriate for gestational age, while 45 were appropriate for gestational age in
the nasoduodenal group. Table 2.1 shows that there were no differences between
the groups in sex, birthweight, crown-heel length, and occipitofrontal
circumference. The original transpyloric group seemed to be of an earlier
gestation and smaller crown-rump length (p = 0.05). The proportion of inborn to
outborn infants was similar in both groups, nine of the inborn infants being fed
nasogastrically having been transferred in utero from other hospitals, while 14 of
the inborn infants who were fed transpylorically were also antenatal transfers (not
significant). The original transpyloric group had significantly poorer Apgar scores








No of infants 35 45
Boys/girls 23/12 32/13 NS
Birthweight (g) 1223 (229) "1132 (213) NS
Gestation (weeks) 28 . 5 (2.0) 27.7 (1.6) <0.05
Crown-rump length (cm) 25.9 (1.5) 25.2 (1.6) <0.05
Crown-heel length (cm) 38.7 (2.5) 37.9 (3.1) NS
Occipitofrontal
circumference (cm) *
26.9 (1.7) 26.1 (2.0) NS
Inborn/outborn 31/4 36/9 NS
Apgar score
at: one minute 6 . 2 (2.7) 3.6 (2.6) <0.001
five minutes 8 . 3 (1.5) 6.3 (2.4) <0.001
* measured on third postnatal day
Values are expressed as mean + -(SD)
Table 2.1: Characteristics of Infants Appropriate for Gestational
Age at Birth
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Table 2.2 shows that of the 35 infants appropriate for gestational age fed
nasogastrically, six died. Five of these had massive intraventricular haemorrhage,
and the sixth was severely birth asphyxiated. Four of the infants originally fed
nasogastrically developed necrotising enterocolitis, which was treated successfully by
total parenteral nutrition and intravenous penicillin, gentamicin and metronidazole.
Of the 45 infants appropriate for gestational age allocated to transpyloric feeding, 21
died, 16 of whom had an intraventricular haemorrhage, three of whom were severely
asphyxiated but post mortem permission was refused, one who was of 24 weeks'
gestation, and one who died of bronchopulmonary dysplasia. Table 2.2 also shows
that 13 of the original nasoduodenal group failed to tolerate nasoduodenal feeding.
Six had severe respiratory distress, tolerated ventilation poorly, and required to be
paralysed: five of these subsequently died, but the other was successfully fed by
nasogastric tube four days later. No infant developed necrotising enterocolitis while
a nasoduodenal tube was in place, although one of the transpyloric group, after
secondary failure of passage of the nasoduodenal tube, was switched to nasogastric
feeding, and necrotising enterocolitis was diagnosed three days later. The increased
radiological exposure of the 34 infants who had successful passage of at least one
nasoduodenal tube is shown (Table 2.2).
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Feeding Method
Nasogastric Nasoduodenal p value
No of infants 35
f
45
Successful feeding to 1600g 25 16
Total no of deaths 6 21 <0.01
No of deaths before
tube passage attempted
4 10
Failure of method 4 13
Cause of failure of method










Recurrent misplacement 0 1
Bile vomits 0 2
X-ray films for tube
positioning* 0 10.6 (7.9)
* Mean + -(SD)
Table 2.2 Outcome of Feeding Methods of Infants Appropriate
for Gestational Age
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Twenty-five infants were fed successfully by nasogastric tube until 1600g, and 16 of the
original transpyloric group also achieved this weight by the nasoduodenal route. Table 2.3
shows that these two groups were similar in all variables measured. In addition, as is
shown in Table 2.4, no differences in growth velocities were identified between the two
groups. Furthermore, no differences between the two successful groups were shown when
f
mean daily fluid and calorie intakes were compared for .each of the first seven postnatal
weeks. The mean rate of displacement of nasoduodenal tube into stomach was 13 times
for these 16 infants.
Feeding Method
Nasogastric Nasoduodenal
No of infants 25 16
No of boys/girls 18/7 11/5
No of outborn/inborn 2/23 4/12
Gestation (weeks) 28.9 (2.1) 28.8 (1.5)
Birthweight (g) 1259 (199) 1303 (140)
Crown-rump length at birth (cm) 25.9 (1.4) 25.9 (1.3)
Crown-heel length at birth (cm) 38.9 (2.3) 39.1 (1.9)
Occipitofrontal circumference
at birth (cm)
27.2 (1.6) 27.2 (1.6)
p = NS for all values
Values are expressed as mean + -(SD).
Table 2.3 Details of Infants Appropriate for Gestational Age






No of infants 25 16
Postnatal weight loss (%) 14.6 (5.4) 17.5 (4.6)
Day of maximal postnatal
weight loss
5.2 (2.3) 5.4 (2.2)
Day to regain birthweight 15.9 (5.1) 16.6 (5.9)
Day to achieve 1600g 29 . 8 (11.5) 28 . 6 (8.6)
Growth of occipitofrontal
circumference (cm/week)
0.8 (0.3) 0.8 (0.4)
Growth of crown-rump length
(cm/week)
0.6 (0.7) 0.7 (0.3)
Growth of crown-heel length
(cm/week)
0.8 (0.2) 0.7 (0.4)
p =NS for all values.
Growth velocities are calculated over the first six weeks
of life. Values are expressed as mean +-(SD)
Table 2.4 Growth Variables of Infants Appropriate for Gestational Age
Fed successfully to 1600g
Discussion
In this study 100 successive infants of birthweight less than 1500g were allocated
alternately to initial nasoduodenal or nasogastric regimens independent of their
clinical condition at birth. However, highly significant differences in Apgar scores at
one and five minutes were obtained by the attending staff who were unaware to
which method of feeding the infant would be allocated. This chance occurrence may
largely account for the greater mortality in the group fed nasoduodenally.
Poor weight gain of infants fed nasojejunally has been described (Roy et al, 1977;
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Whitfield 1982), but a nasoduodenal approach has been claimed to be more
physiological and to carry a lower risk of complications (Van Caillie & Powell,
1975). In our 41 infants appropriate for gestational age who fed successfully to
1600g by the routes originally allocated, no significant differences in growth rates
were identified (Laing et al, 1984), an observation in keeping with the findings of
previous investigators (Pereira & Lemons, 1981).
Concern has been expressed about the association between transpyloric feeding and
the development of necrotising enterocolitis and perforation (Boros & Reynolds,
1974; Siegle et al, 1976). Necrotising enterocolitis can occurwith nasogastric feeding
however (Yu et al, 1979), and all five infants with this disorder in the present study
were being fed nasogastrically at the time of diagnosis. No episode of aspiration of
milk was identified in any of the original 100 very low birthweight infants and no
child fed nasogastrically required to be changed to the transpyloric regimen.
Thirteen of the infants allocated to the original transpyloric regimen did not tolerate
it. In one child the tube failed to pass in seven attempts over 36 hours. Three infants
were successfully transpylorically intubated, but the technique failed thereafter when
a further tube was required. One infant was recurrently intubated without difficulty,
but on eight occasions in four days the tube fell back from the second part of the
duodenum into the stomach, resulting in poor weight gain because of recurrent
method failure. Two infants had frequent bile vomits on two successive days, and,
although no aspiration of vomit was identified, the feeding method was changed to
nasogastric, and the problem promptly resolved. The high rate of displacement of
nasoduodenal tube into stomach (mean 13 times) compares poorly with results
previously achieved in our unit (mean 2.7 times) using the third part of the
duodenum as the optimal endtube site (Glass et al, 1984).
29
While the tip of a transpyloric tube can be positioned by ultrasound techniques, in
many units X-ray films are used for this purpose. The mean of 10.6 X-ray films
required in our study specifically for siting the nasoduodenal tube is recognised as a
disadvantage of the method. One attempted passage of a nasoduodenal tube
resulted in intubation of the right main bronchus: this was identified radiologically,
no milk was administered, the tube was removed, and the infant remained
asymptomatic.
In the present study the group that tolerated nasoduodenal feeding showed no
benefits in either fluid and calorie intake or growth rate when compared with the
infants given intermittent nasogastric feeds. Furthermore, the nasoduodenal method
is of greater complexity and in many centres requires an X-ray film to confirm
endtube site. Intermittent nasogastric feeding should be considered as a suitable
method of feeding low birthweight infants (Laing et al, 1986).
Summary
One hundred successive infants weighing less than 1500g at birth were allocated
alternately to intermittent nasogastric or continuous nasoduodenal feeding
regimens. Eighty were appropriate for gestational age, and of these 25 fed
successfully by nasogastric tube and 16 tolerated nasoduodenal feeding until 1600g.
No significant differences in either calorie intake or growth rates were identified
throughout the seven weeks of the study. Because of the increased complexity and
radiological exposure involved with feeding transpylorically, nasogastric feeding
may be preferred as a method of feeding the low birthweight infant.
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CHAPTER 3
PREVENTION OF RICKETS OF PREMATURITY
Introduction
It has been recognised for over forty years that the preterm infant is predisposed to
rickets (Von Sydow, 1946), yet reports continue on its occurrence in the preterm
population, particularly among extreme low birthweight infants (Kulkarni et al, 1980;
Callenbach et al, 1981).
During human life there is a continued balance between bone formation and
resorption by osteogenic cells (Royer, 1981). The structure of fetal bone has a high
degree of mineralisation, but with an irregular arrangement of collagen fibres and
many osteocytes (Royer, 1981). In older children the typical radiological changes of
rickets include ostepenia, cupping and fraying of the epiphyses and loss of the
provisional zone of calcification. The epiphyses become osteoporotic with poorly
defined margins (Caffey, 1978). Osteopenia usually precedes the appearance of other
radiological features in preterm infants (Von Sydow, 1946) including fraying of the
epiphyses and periosteal reactions. In preterm infants, diffuse demineralisation of
the skeleton has been observed (Glasgow & Thomas, 1977; Geggel et al, 1978;
Cifuentes et al, 1980), especially in the scapulae and ribs (Glasgow & Thomas, 1977).
Many of the features of vitamin D deficiency rickets recognised in older children and
adults are identified in the histological appearances of the bones of preterm infants.
These include widened costochondral junctions, irregularity of the invasion of the
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cartilage plate by blood vessels, broadened osteoid and disordered remodelling of
bone. There are also however reduced osteoblastic activity and marked osteoporosis
(Oppenheimer & Snodgrass, 1980).
During fetal life, calcium is obtained transplacental^ from the mother by an active
transport mechanism (Tsang et al, 1973). Whitsett & Tsang (1980) have suggested
that the calcium may be transported from mother to fetus by an adenosine
triphospate dependent mechanism. It is recognised that maternal bone
mineralisation decreases throughout pregnancy (Lamke et al, 1977) and it may
therefore be that the calcium of the maternal skeleton is sacrificed to supply the
needs of the fetus.
After delivery plasma calcium concentrations fall over the first 48 hours (Hillman et
al, 1977) and subsequently rise throughout the first week of life. It may be that this is
achieved by release of calcium from endogenous stores. In the preterm infant whose
stores may be inadequate hypocalcaemia may result (Tsang et al, 1973). Subsequent
retention of calcium by the preterm infant depends on dietary intake, intestinal
absorption and urinary and faecal losses. Absorption of calcium depends on the
amount ingested by the infant (Shaw, 1976; Barltrop et al, 1977), maturity at birth
(Shaw, 1976) and postnatal age (Fomon et al, 1963; Barltrop & Oppe, 1973; Shaw,
1976). Calcium retention increases with postnatal age in preterm infants (Barltrop &
Oppe, 1973; Shaw, 1976). Calcium absorption may also be related to fat absorption
in preterm infants (Tantibhedhyangkul & Hashim, 1978), since calcium absorption
was significantly increased when medium chain triglycerides were added to a
standard formula.
The rapid growth of the extreme preterm demands a very high calcium intake in
order to match the in utero accretion rates of the fetus at a corresponding gestation
in the third trimester (Shaw, 1976). Calcium accretion rates increase from
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130mg/kg/day (3.3mmol/kg/day) at 28 weeks gestation to 150-155mg/kg/day (3.8-
3.9mmol/kg/day) at term (Shaw, 1976). Preterm infants fed exclusively on human
breast milk have inadequate calcium intake, despite the fact that there is better
absorption of calcium from human breast milk than there is from artificial formulas
(Widdowson, 1965; Southgate et al, 1969; Shaw, 1976). There is a need therefore to
supplement milk intakes with extra calcium to approach intrauterine accretion rates
(Day et al, 1975; Steichen et al, 1980; Glass et al, 1982). In preterm infants increased
calcium supplementation can result in improved bone mineralisation (Day et al,
1975; Glass et al, 1982). The fraction of calcium absorbed in premature infants
ranged between 65% and 97%, and was not influenced by postnatal age, body
weight, or intake of various formulas (Ehrenkrantz et al, 1985).
Photonabsorptiometry has been used to show that giving preterm infants standard
milk formulas, which provide a calcium intake of 100-150mg/kg/day (2.5-
3.7mmol/kg/day), results in poor bone mineralisation (Minton et al, 1979), but
supplementing with calcium to achieve 250mg/kg/day (6.2mmol/kg/day) can result
in improved bone mineralisation (Steichen et al, 1980).
Phosphate is thought to be actively transported from mother to fetus against a
concentration gradient (Economou-Mavrou & McCance, 1958; Khattab & Forfar,
1971). After birth, phosphorus absorption depends again on an active transport
mechanism, this time in jejunum and proximal ileum (Harrison & Harrison, 1979).
Phosphorus absorption seems unrelated to fat absorption (Southgate et al, 1969;
Barnes et al, 1974), is decreased by a high calcium diet (Southgate et al, 1969), and
is increased by vitamin D (DeLuca, 1976). Phosphorus absorption is high in
healthy mature infants: 91% in those breast fed and 76% in those fed proprietary
products (Widdowson, 1981a). The kidney is the principal mode of phosphate
excretion. In preterm infants in the first day of life 90% is reabsorbed at the renal
tubules (Tsang et al, 1973) and in full term infants a low dietary phosphate intake
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increases the fractional tubular reabsorption to 99% (McCrory et al, 1952).
Human milk, which has a low phosphate content, may not provide sufficient
phosphate in the rapidly growing premature infant, resulting in rickets of
prematurity due to phosphate depletion (Sagy et al, 1980).
Parathyroid hormone levels are low in the first few days after birth (David &
Anast, 1974; Root et al, 1976) but in full term neonates the levels are increasing at
48 hours of life (Hillman et al, 1977). The preterm infant shows a corresponding
rise in plasma calcium level at 2 days (Tsang et al, 1973), and the response to
parathyroid hormone increases with increasing gestational age. Parathyroid
hormone acts both to mobilise calcium and phospate to the extracellular
compartment and to increase absorption of calcium and phosphorus from the
small intestine (Forfar, 1976).
Calcitonin inhibits human osteoclastic activity (Allgrove et al, 1981) and enhances
the renal excretion of calcium and phosphate, thus lowering plasma calcium levels
(Allgrove et al, 1981). Calcitonin may help regulate bone mineralisation at birth
(Hillman et al, 1977). Umbilical cord levels of calcitonin are high, especially in
preterm infants (Hillman et al, 1977). The levels then rise by a factor of 2 or 3 over
the next 48 hours, and subsequently decline in the following days (Hillman et al,
1977). It has been suggested that the perinatal elevation of calcitonin levels protects
the neonate against excessive bone resorption (Taylor et al, 1975).
Dietary vitamin D is hydroxylated first in the liver to 25-hydroxycholecalciferol and
then in the kidney to 1,25 dihydroxycholecalciferol (DeLuca, 1976). The latter
increases the absorption of dietary calcium and phosphorus, and also mobilises
calcium and phosphate from bone, thus elevating plasma levels of both (Tsang et
al, 1981). Vitamin D ingested in excess results in hypercalcaemia, and signs
demonstrated by the infants include feeding difficulties, oliguria, irritability,
34
lassitude and poor weight gain (Chesney, 1989). Plasma 25-hydroxyvitamin D
concentrations of newborn infants are strongly correlated with maternal values and
reflect maternal vitamin D status. While full term infants have plasma levels of
25-hydroxycholecalciferol similar to older children, preterm infants have lower
levels which do not increase in the early days of life (Hillman & Haddad, 1975).
Supplementing dietary vitamin D orally or intravenously does not however correct
these low levels in preterm infants (Hillman & Haddad, 1975) and the levels show
no increase until 38 to 42 weeks post-conceptional age. It seems likely therefore
that inadequate absorption of vitamin D is not the cause of the low plasma levels
which seem more strongly linked to maturity of the neonate. Furthermore
Glorieux et al (1981) have shown that the preterm infant seems well able to
convert 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol, as shown by the
3-fold rise in 1,25-dihydroxycholecalciferol levels in infants of 32 to 37 weeks
gestation during the first five days of life when supplemented with 2100i.u. vitamin
D per day. It was previously thought that rickets of prematurity was due to
deficiency of activated vitamin D, but in some studies of preterm infants with
rickets, 1,25-dihydroxycholecalciferol levels are elevated (Chesney et al, 1981;
Steichen et al, 1981).
The enzyme alkaline phosphatase is produced in many tissues, notably bone, liver,
placenta and intestines, from which individual isoenzymes may be identified. Raised
alkaline phosphatase activity is detected in pathological conditions of increased
osteoblastic activity, including Paget's disease, osteomalacia, bone fractures, and
metastatic carcinomas. Alkaline phosphatase activity is also elevated in plasma
during the rapid bone growth of infancy, childhood and adolescence (Harrison &
Harrison, 1979). The enzyme is involved in bone mineralisation and is elevated in
plasma during proliferation of bone osteoblasts (Posen & Doherty, 1981). It is
located on the membrane of the osteoblast-derived "matrix vesicles" and in the
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osteoblasts themselves (Anderson, 1985). Membrane phosphatase may be a
phosphotransferase which transfers phosphate residues into matrix vesicles, and,
using trapped calcium ions, crystallisation can then take place. As mineralisation
occurs both the membrane vesicles and the osteoblasts rupture, leaking alkaline
phosphatase into the general circulation. If bone mineral substrate is deficient,
increased synthesis or activity of alkaline phosphatase occurs, perhaps as an adaptive
process (Lucas et al, 1989).
Rickets of prematurity may be important not only in terms of bone growth but also
because the fractures associated with osteopenia have been implicated in
exacerbating respiratory distress (Glasgow & Thomas, 1977). Early identification and
prevention are therefore important goals. Unfortunately radiological changes are
late features, and photonabsorptiometry, which provides early information, is only
available in a small number of centres. Plasma alkaline phosphatase activity, which is
readily available in most biochemistry laboratories, has been shown to be a possible
adjunct to diagnosis (Glass et al, 1982).
A study was undertaken to examine the effects of adding calcium and then
phosphorus supplements to a proprietary milk formula, to ascertain whether rickets
of prematurity could be prevented both radiologically and biochemically in very low
birthweight infants.
Patients and Methods
From July 1982 to June 1984 ninety-seven infants weighing less than 1500g at birth
were fed enterally from birth for 47 days. For the first five days all were fed SMA
Gold Cap formula. Thereafter, sequential cohorts (groups A to E) were given
formulas made by diluting SMA Gold Cap concentrate liquid with water and
additive solutions (Table 3.1). For details of supplemented formulas see
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Appendices 3 and 4. The final concentrations in the formulas were sodium 26.5
mmol/L (61.2mg/dL), potassium 24.5 mmol/L (96.mg/dL) and chloride 23.8
mmol/L (104mg/dL). The quantities of additives were developed empirically.
Part substitution of calcium chloride with calcium gluconate, and sodium chloride
with sodium bicarbonate was repeated recurrently until the pH of SMA Gold Cap,
6.64 was achieved within 0.1 unit. These derived volumes are detailed in Appendix
3. Characteristics of the five groups are shown in Table 3.2. Concentrations of
calcium and phosphorus were varied (Table 3.3). All infants received supplements
of Vitamin D2 460i.u./day for the duration of the study.
% wt/vol
Sodium chloride 5.84
Sodium bicarbonate 8. 3
Calcium gluconate 10. 0
Calcium chloride 13.4
Potassium phosphate 17.42
Potassium chloride 15. 0
Table 3.1: Solutions added to SMA Gold Cap Concentrate.




Group A 18 1.36 (0.23) 31.1 (0.9)
Group B 18 1.41 (0.23) 30.2 (1.5)
Group C 16 1.49 (0.33) 29.1 (2.0)
Group D 22 1.23 (0.17) 29.5 (1.7)
Group E 23 1.26 (0.19) 29.2 (2.1)
Values expressed as mean + -(SD)











Group A 11.0 10.7 , 1.0
Group B 21.0 10.5 2 . 0
Group C 31.2 10.7 2.9
Group D 31.2 15.7 2 . 0
Group E 31.2 20.0 1.6










Group A 44 33 1.3
Group B 84 32 2 . 6
Group C 125 33 3.7
Group D 125 49 2 . 6
Group E 125 62 2 . 0
Table 3.3b: Calcium and Phosphorus Contents of Formulas Used
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The plasma calcium and phosphate concentrations and alkaline phosphatase activity
in each infant were measured at age 5 to 10 days and in each subsequent week for six
weeks. Plasma calcium was measured by atomic absorption spectrometry (Cali et al,
1973), and phosphate and alkaline phosphatase by spectrophotometric methods
based on phosphomolybdate reduction (Gindler & Ishinzaki, 1969) and 4-nitro
phenylphosphate hydrolysis (Morgenstern et al, 1965) respectively. Plasma calcium
and phosphate concentrations and alkaline phosphatase activities were compared by
analysis of variance followed by pairwise comparisons using the Student-Newman-
Keuls procedure (Sokal & Rohif, 1969). The mean daily calcium and phosphorus
intakes of each infant were calculated.
Radiographs were obtained in 80 infants examined routinely at six weeks of age. At
the end of the study all radiographs were assessed independently of clinical and
biochemical data by a paediatric radiologist. Bone demineralisation, metaphyseal
changes, and periosteal reactions were recorded. Statistical analysis of radiological
abnormality was by chi-square testwith the Yates correction comparing group Awith
the other four groups combined. All other statistical analysis was by Student t test.
Permission to carry out the study was obtained from the Reproductive Medicine
Ethical Subcommittee, Simpson Memorial Maternity Pavilion.
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Results
The mean daily intakes of calcium and phosphorus (Tables 3.4 and 3.5) increased
from week two, when supplementation began, in keeping with the extra calcium
and phosphorus content of the milk (Table 3.3). Plasma calcium and phosphate
concentrations were measured weekly, and analysis of variance showed no
significant differences among the five groups in plasma calcium (Table 3.6) at any
time, but plasma phosphate (Table 3.7) showed differences at weeks 1 to 6, p
<0.05 except for week 4 (p <0.01): groups A, B and C were not significantly
different in plasma phosphate level at any time, but groups D and E differed from
group A at weeks 4, 5 and 6, from group B at weeks 1, 2, 3 and 4, and from group C
at weeks 2, 4 and 5. No differences in plasma alkaline phosphatase activity among
groups were observed during the first postnatal week (Table 3.8).
In the subsequent six weeks, analysis of variance showed highly significant
differences in alkaline phosphatase activities among the five groups (p <0.01 or p
<0.001). Follow-up tests showed significant differences between groups A and B
and between groups A and D (or E) for all six weeks, and also between groups A and
C at 3, 4, 5 and 7 weeks, and groups C and D (or E) at weeks 4, 5 and 6. No
differences between groups B and C nor between groups B and D were evident. In
addition, plasma alkaline phosphatase activity was compared with gestational age
values previously established in our unit (Glass et al, 1982), and shown in
Appendix 5. Figure 3.1 shows that groups A, B and C had significantly elevated
levels from 33 postmenstrual weeks until the end of the study, but the mean for
group D was not significantly raised until the last week of the study period. The
mean alkaline phosphatase activity in group E remained within the normative



















A B C D E
(0.4) 2.4 (0.9) 1.7 (0.5) 1.7 (0.7) 1.3 (0.6)
(0.5) 4 . 3 (0.5) 5.4 (0.9) 5.4 (1.4) 5.1 (1.4)
(0.3) 4.3 (0.8) 5.8 (0.4) 5.6 (1.1) 5.7 (1.1)
(0.3) 4 . 5 (0.5) 5.9 (0.4) 5.9 (0.8) 6.0 (0.5)
(0.3) 4.4 (0.8) 6.0 (0.5) 5.9 (0.6) 6.1 (0.6)
(0.3) 4 . 5 (0.3) 6 . 1 (0.4) 6.1 (0.5) 6.2 (0.6)
(0.2) 4 . 6 (0.4) 5.7 (0.9) 5.4 (0.8) 5.4 (0.8)
Values are expressed as mean + -(SD)
Table 3.4a: Intake of Calcium Expressed as Daily Mean for Each Week
Calcium Intake
(mg/kg/day)
A B C D E
(16) 96 (36) 98 (20) 98 (28) 54 (24)
(20) 172 (20) 216 (36) 216 (56) 204 (56)
(12) 172 (32) 232 (16) 224 (44) 228 (44)
(12) 180 (20) 236 (16) 236 (32) 240 (20)
(12) 176 (32) 240 (20) 236 (24) 244 (24)
(12) 180 (12) 244 (16) 244 (20) 248 (24)
(8) 184 (16) 228 (36) 216 (32) 216 (32)
Values are expressed as meant-(SD)




Group A B C D E
Week
1 1.3 (0.3) 1.5 (0.3) 1.1 (0.2) 1.2 (0.3) 1.2 (0.4)
2 1.7 (0.6) 1.9 (0.4) 1.9 (0.3) 2 . 8 (0.6) 3 . 3 (0.8)
3 1.9 (0.5) 2 . 1 (0.4) 2 . 0 (0.2) 2.9 (0.5) 3.7 (0.6)
4 1.9 (0.5) 2 . 1 (0.4) 2 . 0 (0.1) 3 . 0 (0.4) 3.9 (0.3)
5 1.9 (0.5) 2 .1 (0.5) 2 . 0 (0.2) 3 . 0 (0.3) 3.9 (0.4)
6 1.9 (0.4) 2 .1 (0.4) 2 .1 (0.1) 3 . 1 (0.3) 4 . 0 (0.4)
7 2.0 (0.4) 2.2 (0.2) 2 . 1 (0.2) 2.9 (0.3) 3 . 6 (0.4)
Values are expressed as mean + -(SD)
Table 3.5a: Intake of Phosphorus Expressed as Daily Mean for Each Week
Phosphorus Intake
(mg/kg/day)
Group A B C D E
Week
1 39 (9) 45 (9) 33 (6) 36 (9) 36 (12)
2 51 (18) 57 (12) 57 (9) 84 (18) 99 (24)
3 57 (15) 63 (12) 60 (6) 87 (15) 111 (18)
4 56 (15) 63 (12) 60 (3) 90 (12) 117 (9)
5 57 (15) 63 (15) 60 (6) 90 (9) 117 (12)
6 57 (12) 63 (12) 63 (3) 93 (9) 120 (12)
7 60 (12) 66 (6) 63 (6) 87 (9) 108 (12)
Values are expressed as mean + -(SD)




Group A B C D E
Postnatal
age (weeks)
1 2.29(0.26) 2.27 (0.27) 2.33(0.24) 2.32(0.27) 2.02(0.41)
2 2.35(0.24) 2.49(0.18) 2.51(0.22) 2.42(0.22) 2.42(0.20)
3 2.42(0.14) 2.44(0.12) 2.43(0.19) 2.43(0.08) 2.46(0.11)
4 2.35(0.12) 2.36(0.24) 2.41(0.12) 2.36(0.13) 2.40(0.09)
5 2.39(0.12) 2.40(0.14) 2.40(0.12) 2.34(0.12) 2.43(0.09)
6 2.32(0.16) 2.39(0.10) 2.41(0.17) 2.37(0.08) 2.40(0.11)
7 2.29(0.21) 2.44(0.11) 2.37(0.18) 2.33(0.12) 2.40(0.11)
Values are expressed as mean + -(SD)




Group A B C D E
Postnatal
age (weeks)
1 1.84(0.46) 1.72(0.48) 1.89(0.40) 2.20(0.40) 2.14(0.39)
2 2.07(0.31) 1.90(0.47) 2.00(0.51) 2.36(0.42) 2.52(0.49)
3 2.12(0.35) 1.99(0.44) 2.02(0.33) 2.34(0.35) 2.56(0.61)
4 1.99(0.26) 2 . 02 (0.32) 2.10(0.37) 2.44(0.39) 2.61(0.39)
5 2.03(0.29) 2 .20(0.36) 2.12(0.49) 2.46(0.43) 2.60(0.25)
6 2.01(0.22) 2.22(0.40) 2.07(0.42) 2.47(0.57) 2.73(0.64)
7 2.08(0.37) 2.39(0.24) 2.11(0.38) 2.25(0.36) 2.80(0.87)
Values are expressed as mean + -(SD)










5 <0 . 01
6 <0. 05
7 inooV
Significance expressed as p values
Table 3.7b: Significance of differences in plasma phosphate concentrations:
phosphate-supplemented groups D and Ecompared to phosphate-unsupplemented groups













26+27 28+29 30+31 32+33
Weeks
34+35 36 Term
Mean Alkaline Phosphatase Activity (i.u./L) for Each Group of Infants Plotted
According to Postmenstrual Age in Weeks
Mean activities during successive postnatal weeks for each of groups A,B,C,D and E are





Group A B C D E
Postnatal
age (wk)
1 297 (64) 281 (71) 260 (60) 287 (119) 247 (67)
2 393 (137) 289 (65) 328 (146) 260 (102) 257 (79)
3 488 (240) 333 (79) 356 (135) 253 (83) 244 (59)
4 470 (169) 317 (97) 377 (124) 263 (91) 235 (64)
5 496 (207) 312 (104) 385 (139) 258 (87) 238 (65)
6 506 (263) 325 (141) 396 (152) 254 (89) 236 (67)
7 589 (280) 354 (168) 416 (152) 324 (137) 240 (61)
Values are expressed as mean + -(SD)
Table 3.8: Variations in Plasma Alkaline Phosphatase Activity with Postnatal Age.
No radiological differences were identified among groups B, C and D, but group A had a
significantly higher incidence of radiological abnormalities (p <0.001) as shown in Table
















2 8 13 19 22
?osteoporosis
?normal
1 1 0 1 0
Osteoporosis 8 1 2 2 1
Metaphyseal change 2 0 1 1 0
Periosteal reaction 1 0 0 0 0
No X-ray study 7 8 1 1 0
Table 3.9: Radiological Bone Changes in Groups of Infants
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Discussion
The calcium and phosphorus content of low-solute formulas based on the
composition of mature human milk cannot meet the requirements of the preterm
infant if accretion of these elements is to continue at intrauterine rates (Stearns,
1939; Shaw, 1976). Recent studies of preterm infants at 40 weeks postmenstrual
age have continued to show deficits in bone mineral accretion relative to full term
infants observed at birth (James et al, 1986a; Horsman et al, 1989) and
photonabsorptiometry has demonstrated that poorer mineralisation occurs
predominantly in infants of birth weight less than lOOOg (James et al, 1986b).
Calcium retention increases with the amount of calcium ingested (Barltrop &
Oppe, 1973), and with high calcium intake can be greater in preterm infants than
occurs in utero (Day et al, 1975). Phosphorus supplementation improves calcium
retention in preterm infants fed human milk (Senterre et al, 1983). Rowe et al
(1984) showed that calcium and phosphate intakes of infants fed human milk were
two to three times less than those of infants fed formula, and had 50% reduction in
calcium and phosphate retention. They recommended a cautious increase in
intake of both substrates as supplements to human milk. Although this work
implies that there is a lesser need for supplementing the formula-fed infant, the
varieties of calcium and phosphorus content as well as calcium/phosphorus ratio
of formulas for low birthweight infants emphasise the lack of consensus on their
nutritional requirements. Absorption of calcium is influenced by postnatal age
(Shaw, 1976), endogenous intestinal secretion (Barltrop & Oppe, 1973), fat
absorption (Widdowson, 1965), metabolism of vitamin D (Hillman et al, 1979) and
calcium/phosphorus ratio (Moya & Domenech, 1982). The ratio of
calcium/phosphorus retained by the fetus in the intrauterine environment varies
through the last trimester (Moya & Domenech, 1982), but it is not known whether
preterm infant requirements change in a similar manner.
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The present studies used supplementary calcium and phosphate aiming to restore
mineral accretion rates to values which resembled in utero values, in the
expectation of minimising the complications of osteopenia of prematurity.
Horsman et al (1989) have subsequently shown that preterm infants with
inadequate mineralisation were on average 3.8cm shorter at 65-100 weeks
"postconception" than those born at full term, but with normal bone mineral
content. Although Horsman's study implies catch-up mineralisation after term, as
judged by photonabsorptiometry, it must be born in mind that studies of a 1cm
length of forearm may be invalid for other parts of the skeleton, including the
metaphyses. Furthermore inadequate mineralisation of the forearm may be partly
masked by the decreased linear growth of the long bones implied by Horsman's
work. This criticism also applies to the work of Pittard et al (1990), who
demonstrated, also by photonabsorptiometry, an apparent catch up in bone
mineralisation in a very low birthweight population at 16 weeks after delivery.
Lucas et al (1989) showed a slower linear growth rate in the neonatal period in
infants with osteopenia of prematurity, and that such children were significantly
shorter at 9 and 18 months post term. Excellent catch-up growth has been
described in classical rickets (Hess, 1930), but in neonatal rickets it is perhaps
surprising that normal growth patterns are not achieved even after intake and
absorption of calcium and phosphorus have reached normal infant values (Salle et
al, 1986) and the bones have remineralised (Chan & Mileu, 1985). The present
data demonstrate that calcium supplementation of a low-solute milk can prevent
the radiological changes of rickets in preterm infants, thus confirming previous
findings using radiodensitometric methods and cortical thickness as a means of
studying bone formation (Day et al, 1975). These results complement the
observation of other investigators (Steichen et al, 1980) that, using a similar
calcium and phosphorus supplemented milk, extrauterine bone mineralisation
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analysed by direct photonabsorptiometry approximates to intrauterine bone
mineralisation.
Plasma alkaline phosphatase activity measured sequentially can be used as a
biochemical marker of rickets of prematurity (Glass et al, 1982). Normative data
previously established in our institution are based on plasma alkaline phosphatase
activity measured at one week of life in preterm infants at differing postmenstrual
ages at birth (see Appendix 4). Worries that alkaline phosphatase from liver or
placenta might invalidate this measurement have subsequently proved unfounded
(Crofton, 1987; Crofton & Hume, 1987). Radiological assessment of X-rays of
preterm infants throughout their clinical course shows a significant association
between osteopenia of prematurity and alkaline phosphatase activity elevated
above the normative range (Glass et al, 1982). Although some workers have
expressed reservations about the value of alkaline phosphatase activity as a
measure of rickets of prematurity (Mcintosh et al, 1984; Walters et al, 1986)
further studies have shown significantly impaired linear growth after elevated
neonatal alkaline phosphatase activities (Cooper et al, 1985; James et al, 1985).
Indeed Lucas and coworkers (1989) showed in low birthweight infants that high
plasma alkaline phosphatase activity was strongly associated with impaired linear
growth in the neonatal period, and that this deficit persisted at 9 and 18 months
corrected age. Infants fed with milk supplemented only with calcium may still
have increased plasma alkaline phosphatase activity (Laing et al, 1985). The
present study demonstrated that plasma alkaline phosphatase activity can be kept
within a normative range provided that proprietary milk was supplemented with
adequate quantities of both calcium and phosphate. Rickets of prematurity is
largely preventable, but further work is required to define the precise nutritional
requirements for appropriate bone growth in the preterm infant.
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Summary
Ninety-seven infants weighing less than 1500g at birth were fed enterally from
birth until day 47. Group A (18 infants) were given SMA Gold Cap, calcium
content 11 mmol/L and phosphate content 10.7 mmol/L; group B (18 infants)
supplementary calcium to 21mmol/L; group C (16 infants) further calcium
supplementation to 31.2mmol/L; group D (22 infants) milk with calcium content
31.2mmol/L and phosphorus supplementation to 15.7mmol/L; and group E (23
infants) milk with calcium content 31.2mmol/L and phosphorus supplementation
to 20.0mmol/L. The addition of calcium reduced the radiological evidence of
rickets, and combined calcium and phosphorus supplementation maintained
plasma alkaline phosphatase activity within the normal range for six weeks (group
D) and throughout the study period (group E).
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CHAPTER 4
THE EFFECT OF CALCIUM AND PHOSPHORUS ON MAGNESIUM
METABOLISM
Introduction
The calcium and phosphorus content of human milk or low solute formulas cannot
meet the requirements of preterm infants if accretion of these elements is to
continue at intrauterine rates (Steichen et al, 1980; Cooke & Nichoalds, 1986).
Formulas supplemented with calcium and phosphorus can achieve postnatal
accretion comparable to intrauterine rates (Day et al, 1975; Giles et al, 1987).
However, avoidance of overt bone disease in preterm infants can be achieved at
retentions of calcium and phosphorus lower than fetal accretion (Ziegler, 1985;
Glass, 1987). In addition excess dietary calcium supplementation can result in
supermineralisation (Day et al, 1975) and fat malabsorption (Chappell et al, 1986).
Information on the absorption and retention of magnesium in preterm infants is
limited (Greer & Tsang, 1985). Factors which may affect magnesium metabolism
include intakes of magnesium (Benjamin et al, 1943), calcium (Wilkinson, 1976),
phosphorus (Wilkinson, 1976; Widdowson et al, 1963), as well as vitamin D
(Wilkinson, 1976), fat intake (Okamoto et al, 1982), gestational age (Okamoto et
al, 1982) and postnatal age (Tantibhedhyangkul & Hashim, 1978).
Magnesium is the second most abundant intracellular cation, and it is required for
many enzymatic reactions, particularly those that require adenosine triphosphate.
About 50% of total body magnesium is in bone, and most of the rest is
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intracellular. Approximately 35% of total magnesium is bound to serum protein.
Fetal magnesium levels are higher than maternal concentrations because of an
active transplacental transport system, and yet in experimental magnesium
deficiency in rats the fetus becomes relatively more deficient than the mother
(Dancis et al, 1971).
Accumulation of magnesium by the human fetus is remarkably constant from 24 to
36 weeks gestation, varying from 3.7 to 3.8mg/kg body weight/day (Shaw, 1973).
Plasma magnesium concentrations are similar between preterm and term infants
at birth, and rise over the first 48 hours to a level maintained at the end of the first
week (Hillman et al, 1977), although in infants receiving cow's milk formulas the
plasma magnesium may not rise due to the higher phosphate load (Anast, 1964;
David & Anast, 1974). In postnatal life magnesium is absorbed in the small
intestine (Graham et al, 1960; Brannon et al, 1976) and in the preterm infant this
absorption is increased in the presence of parathyroid hormone (Tsang et al,
1973). A positive association between magnesium and fat absorption has been
shown in full term infants (Widdowson, 1965) and in preterm infants
(Tantibhedhyangkul & Hashim, 1978). The dietary intake of magnesium both
from breast milk and from proprietary formulas is greater than the needs of the
full term infant by several times. More than 50% of magnesium is absorbed and so
dietary deficiency seems unlikely (Widdowson, 1981). Intrauterine accretion rates
are easily met by human milk which contains approximately 1.7mmol of
magnesium per litre (4mg/dL), and by standard available proprietary formulas
with a magnesium content of 1.7 to 4.3mmol/L milk (4 to lOmg/dL). With
advancing postnatal age the very low birthweight infant shows increasing
magnesium absorption and retention (Dauncey et al, 1977). In this study of infants
weighing less than 1500g at birth, mean magnesium absorption over the period of
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the study was 43% of the intake, but retention was only 25% because of urinary
losses. Calcium and magnesium seem to have a close metabolic relationship with
each other. Both exist in blood in three forms: protein-bound, complexed to salts,
and ionised. Hypomagnesaemia results in hypocalcaemia partly by decreasing
parathyroid hormone synthesis and release (Anast et al, 1972) and partly by
altering end organ responsiveness to parathyroid hormone (Chase et al, 1974)
which results in reduced calcium absorption and also decreased
calcium/magnesium exchange in bone (Chase et al, 1974). Intramuscular
magnesium sulphate has been recommended as the treatment of choice for
symptomatic neonatal hypocalcaemia, whether or not there is hypomagnesaemia
(Turner et al, 1977). Late onset hypocalcaemia with associated hypomagnesaemia
will not respond to supplemental calcium therapy unless the magnesium deficiency
is treated (Cooper et al, 1985).
Hypermagnesaemia may occur in the newborn period secondary to maternal
treatment with magnesium sulphate for eclampsia, pre-eclampsia, or as a tocolytic
in premature labour. Hypermagnesaemic neonates have elevated ionised calcium
concentrations in serum, and it may be that magnesium and calcium compete with
one another for protein binding sites in the plasma (Liu et al, 1988). Infants born to
toxaemic mothers who have been treated with continuous infusions of magnesium
sulphate may be flaccid, cyanotic and unresponsive, in association with high
neonatal plasma magnesium levels (Lipsitz & English, 1967). Elevated plasma
magnesium levels in the newborn period can cause apnoea, lethargy, hypotonia,
hyporeflexia, poor suck and delayed passage of meconium, although signs and
symptoms do not correlate well with plasma magnesium levels (Lipsitz, 1971).
Exchange transfusion has been advocated as a method of reducing plasma
magnesium levels quickly, but the concentrations spontaneously decrease over 48
hours along with the disappearance of symptomatology. Infusion of calcium salts
has been advocated to decrease some of the symptomatology (Lipsitz, 1971).
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Hypomagnesaemia impairs parathyroid hormone secretion (Anast et al, 1972,
1976; Suh et al, 1973; Rude et al, 1978), and may decrease the end organ response
to parathyroid hormone (Muldowney et al, 1970; Rude et al, 1976). In infants with
renal failure hypomagnesaemia may occur in association with acidosis or
hypocalcaemia, but depressed concentration of plasma magnesium correlates best
with the degree of hyperphosphataemia (Ghazali et al, 1972). Newborn infants
with hypomagnesaemia may be separated into a group who have transient
hypomagnesaemia, and a second group who have chronic primary
hypomagnesaemia with secondary hypocalcaemia (Salet & Fournet, 1970; Anast,
1975). This latter is a rare condition in which there is a congenital abnormality of
an intestinal transport mechanism for magnesium. The administration of
magnesium to these patients results in concomitant increases in parathyroid
hormone and calcium levels, along with raised renal phosphate clearance. In many
infants with transient hypomagnesaemia, both the plasma magnesium and calcium
levels return to normal when the magnesium deficiency is corrected. It has been
shown by in vitro bone culture that magnesium concentrations in the culture
medium can lead to ionic exchange of magnesium for calcium at the bone surface,
causing an increase in magnesium bound to the bone matrix and a shift of calcium
from the bone surface into the culture medium (Macmanus & Heaton, 1970).
The purpose of the study in this chapter was to measure magnesium absorption
and retention in groups of preterm infants fed a low solute formula variously
supplemented with calcium, phosphorus and magnesium, and to define the inter¬
relationships between these minerals.
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Patients and Methods
From February 1983 to December 1985 fifty-six male infants weighing less than
1500g at birth, and of gestational age less than 32 weeks, were fed enterally at
birth for 47 days. Nasogastric feeding of low birthweight infants from birth is the
preferred route in our neonatal unit. For the first five days, all were fed SMA Gold
Cap formula (Wyeth Laboratories, Philadelphia). Thereafter, sequential cohorts
(group A-F) were given formulas varying in calcium, phosphorus or magnesium
content (Table 4.1). Informed consent was obtained from the parents of all infants
and the study was passed by the Paediatric/Reproductive Medicine Ethics of
Medical Research Sub-committee of the Lothian Health Board. Infants were
excluded only if parental consent was refused (approximately 5%) or if they
received parenteral nutrition (two infants). Of the 56 infants, 33 required
ventilatory support, mainly because of respiratory distress syndrome. These
ventilated infants numbered six in group A, she in B, five in C, five in D, five in E,
and six in group F. In the majority, endotracheal tubes were removed in the first
week of life, but one infant in group B, one infant in group C and one infant in
group F required assisted ventilation for bronchopulmonary dysplasia through the
fourth balance period. Frusemide lmg/kg/day was given to one infant in group C
(first balance period only), one infant in group E (fourth balance only) and
another in group E (third and fourth balances).
Eighteen male infants 32-34 weeks gestation and appropriately grown for
gestational age were enterally fed from birth. For the first five days all were fed
SMA Gold Cap formula, and thereafter sequential cohorts (groups G and H) were
given formulas differing in magnesium content. Of the 18 infants, nine required
ventilatory support; six infants in group G, and three in group H. All infants were
extubated in the first week of life. No infant received diuretics during the balance
period and no infant was parenterally fed.
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The method of preparation of formulas varying in calcium and phosphorus is
described in Appendices 3 and 4 and has also been published (Giles et al, 1987).
SMA Gold Cap concentrate was diluted with salt solution allowing preparation of
formulas which varied only in calcium, phosphorus and magnesium content.
Magnesium sulphate 50% wt/vol was used as a stock solution when formulas were
supplemented with magnesium.
Fluid intake targets were the same in all groups, and soon after birth a peripheral
intravenous infusion was started based on 9.5% dextrose with sodium 2.0mmol/L
(46mg/dL). Amino-acid and lipid solutions were not given. At three hours a
nasogastric feeding tube was passed and milk feeds began at 0.5ml/hour for
infants of birthweight less than lOOOg, or 1 ml/hour for infants of birthweight of
lOOOg or greater. Six-hourly increments of milk (by 0.5ml/hour for the lighter
group, and lml/hour for the heavier group) were planned. Fluid intake began at
50ml/kg/day on day one, and increased by 25ml/kg/day each day to a maximum
of 200ml/kg/day. Infants less than 1500g were fed initially by intermittent hourly
nasogastric feeds, progressing to two-hourly intermittent nasogastric feeds at 1750g
weight, three-hourly intermittent nasogastric feeds at 1800g weight, and thereafter
three-hourly bottle feeds on an individual basis. Infants of birthweight greater
than 1500g were fed initially by intermittent hourly nasogastric feeds and
progressed on an individual basis. All infants in groups G and H were fed hourly
by nasogastric tube by the time of the day 10 balance, with the exception of one
infant (in group G) who was given three-hourly nasogastric feeds. Intake volumes
were measured by syringe in tube fed infants; in bottle fed infants, amounts offered
and residual volumes were also measured by syringe.
Three-day balance studies were started at 10, 20, 30 and 40 days of life. Each
infant was weighed daily on an integrated electronic balance (Mettler 515, Mettler
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Electronics Corp., Anaheim, California). During the balance periods the infants
were washed only with distilled water and no creams or ointments were applied to
the skin. At the beginning of the balance study, usually at 8am, a carmine marker
(50mg) was given by nasogastric tube, and urine was then collected for the
subsequent 72 hours in a neonatal ileostomy bag (Salts & Son Ltd., Birmingham,
England). The bag was attached to the infant's perineum with Comfeel (Coloplast
International A/S, Espergaerde, Denmark). When urine was passed the bag was
immediately emptied by syringe suction via an indwelling tube in the bag, and the
urine collected was stored in an acid-washed polyethylene bottle. Each day the
total volume of urine passed was measured and recorded, and then an aliquot was
taken for analysis. Stool and urine spillages were collected on 24cm ashless filter
papers (Whatman 541, Whatman Chemical Separation Inc., Clifton, New Jersey).
Stool collection began at the time of the appearance of the carmine marker.
Seventy-two hours after the giving of the first carmine marker, a second carmine
marker was administered, and stool collection continued until this marker
reappeared. Filter papers and stools from each 24-hour period were transferred to
acid-washed Pyrex beakers, in which they were dried overnight at 90deg C before
being ashed at 420deg C for 2 days in a Carbolite muffle furnace. The ash was
then dissolved in concentrated nitric acid (Aristar grade, BDH Chemicals Ltd.,
Poole, England), using 1ml for urine and 2ml for stool. Distilled deionised water
was then added to the digest before filtering through Whatman 541 filter paper.
The filtrate was made up either to 10 or 20ml with water used to rinse the beaker
and filter. The filtrate was then stored at 4deg C until analysed. Similarly vomitus
was collected on filter paper and processed in an identical manner. Calcium was
measured in the filtrates and fresh urine by atomic spectrometry (Instruction
Manual, Pye Unicam SP191 Atomic Absorption Spectrophotometer. Cambridge:
Pye Unicam). Phosphorus was measured in the same sample by a
spectrophotometric method based on phosphomolybdate reduction (Fiske &
Subbarow, 1925). After subtraction of predetermined blank values for Whatman
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filter papers and acid, the following calculations could be made:
Mean Net absorption = Intake - (Vomitus + Stooll
mg or mmol/kg/day Mean weight for 3-day balance
Mean Retention = Intake - fVomitus + Stool + Urinel
mg or mmol/kg/day Mean Weight for 3-day balance
Venous plasma calcium, phosphorus and magnesium concentrations were
measured weekly.
Statistical Methods
The effect of calcium and phosphorus supplementation was tested by comparing
groups A, B and C with groups C, D and E respectively, these having been
previously analysed for the effect of dietary intake on their retention and
absorption in preterm infants (Giles et al, 1987). The effect of supplementary
magnesium (group F) was tested using the same analysis technique i.e. unbalanced
mixed model analysis of variance using the programme BMDP3V (Dixon, 1985), in
which pairwise comparison of means for each significant fixed factor (time and
group) at each level of the other factor was performed if interaction occurred.
Otherwise a pairwise test of significant main effects was carried out at all levels of
the other factors combined. Bonferroni corrections were used in the pairwise tests
to account for multiple testing.
To examine the effects and possible interaction of gestational age and magnesium
dietary intake (groups E, F, G and H at 10 - 13 days postnatal age) multiple linear
regression was used, with gestational age and dietary magnesium content being the
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two factors classifying each infant into one of the four groups. The interaction
between these two factors was tested first, and when this was not significant an
additive model was fitted to the data and the significance of each main effect
tested.
Results
In the very low birthweight (VLBW) infants, groups A to F, no differences in
gestation, birth weight, or weight gain patterns were observed (Table 4.2). In low
birthweight (LBW) infants (groups G and H) birth weights and gestational ages
were comparable (Table 4.2). The VLBW infants (groups A to F) were of lower
gestational age (p <0.001) and lower birth weight than LBW infants, groups G and
H.
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Group Calcium Phosphorus Magnesium
(mmol/L) (mmol/L) (mmol/L)
VLBW
A 11.0 11.0 2.2
B 21.2 11.0 2.2
C 31.3 11.0 2 . 2
D 31.3 16.7 2.2
E 31.3 21.3 2 . 2
F 31.3 21.3 4.4
LBW
G 31.3 21.3 4.4
H 31.3 21.3 2 . 2
Table 4.1a: Calcium, Phosphorus and Magnesium Contents of Milk Formulas
Group Calcium Phosphorus Magnesium
(mg/dL) (mg/dL) (mg/dL)
VLBW
A 44.5 33 5.35
B 84 . 5 33 5.35
C 124 . 5 33 5.35
D 124.5 50 5.35
E 124 . 5 64 5.35
F 124 . 5 64 10.70
LBW
G 124 . 5 64 10.70
H 124 . 5 64 5.35












A 10 1.35 (0.08) 29 . 9 (1.3) 860 (523-1084)
B 9 1.27 (0.14) 29 . 9 (1.8) 855 (688-1058)
C 10 1.30 (0.13) 29.8 (1.3) 824 (569-1080)
D 9 1.44 (0.30) 29 . 4 (1.3) 770 (450-921)
E 8 1.36 (0.20) 29 . 8 (1.6) 825 (751-949)
F 10 1. 18 (0.19) 28 . 8 (1.4) 734 (526-919)
LBW
G 11 1.85 (0.32) 32 . 9 (1.3)
H 7 1. 82 (0.20) 32 . 6 (1.3) ...
Table 4.2: Characteristics ofGroups of VLBW and LBW Infants
Calcium, Phosphorus and Magnesium Intakes
Calcium, phosphorus and magnesium contents of the milk formulas are shown in Table
4.1. Milk intakes of the groups throughout the study ranged from 169 + -25ml/kg/day to
197 + -4ml/kg/day (mean + -SD), with no differences between the groups at the four
balance periods. Magnesium intakes were the same in magnesium supplemented infants
(groups F and G) and were higher (p <0.001) than in the unsupplemented infants
(groups A to E, and H), who had comparable magnesium intakes (Table 4.3).
Phosphorus intakes in groups A to C, with no additional phosphorus, were the same;
intakes in groups E to H, with the highest phosphorus supplementation, were higher
than in the unsupplemented groups A to C (p <0.001) (Table 4.3). Phosphorus intake
in group D, with intermediate phosphorus supplementation, was higher than in groups A
to C (p <0.001) but lower than that in groups E to H (p <0.001). Calcium intakes were









A 2 . 14 (0.15) 1. 58 (0.10) 0.43 (0.03)
B 3.80 (0.38) 1.48 (0.15) 0.40 (0.04)
C 5.83 (0.40) 1. 55 (0.10) 0.42 (0.03)
D 5.98 (0.45) 2 .40 (0. 18)' 0.43 (0.03)
E 5.83 (0.40) 3 . 00 (0.23) 0.42 (0.03)
F 5.90 (0.48) 3 . 00 (0.25) 0.85 (0.07)
LBW
G 5.70 (0.63) 2 .93 (0.33) 0.82 (0.09)
H 5.65 (0.78) 2 .90 (0.40) 0.41 (0.06)
Values expressed as mean+-(SD)
Table 4.3a: Daily Intakes of Calcium, Phosphorus and Magnesium








A 85 (6) 63 (4) 10.24 (0.7)
B 151 (15) 59 (6) 9.55 (1.0)
C 233 (16) 62
. (4) 10. 01 (0.6)
D 239 (18) 96 (7) 10.29 (0.7)
E 233 (16) 120 (9) 10. 02 (0.8)
F 236 (19) 120 (10) 20. 14 (1.6)
LBW
G 228 (25) 117 (13) 19.55 (2.1)
H 226 (31) 116 (16) 9 . 67 (1.3)
Values expressed as mean + -(SD)
Table 4.3b: Daily Intakes of Calcium, Phosphorus and Magnesium
for Each Group throughout the Study
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that in groups A or B (p <0.001). Calcium intake in group B infants with intermediate
calcium supplementation was higher than in group A (p <0.001) but lower than in the
groups C to H (p <0.001).
Plasma Calcium, Phosphorus and Magnesium Concentrations
Tables 4.4, 4.5 and 4.6 show the plasma calcium, phosphorus and magnesium levels
measured during each balance period. Mean plasma calcium concentrations for all
groups ranged from 2.30-2.59mmol/L (9.18-10.34mg/dL) with no differences between or
within the groups. Mean plasma phosphorus concentrations for all groups were within
the range 1.85-2.66mmol/L (5.9-8.5mg/dL) and mean plasma magnesium
concentrations were in the range of 0.75-0.97mmol/L (1.80-2.33 mg/dL). Plasma
phosphorus concentration was higher in group A infants compared with group B at 10
and 20 days (p <0.05)) and group C at 20 days (p <0.05). Plasma phosphorus was lower
in group C compared with groups D and E at 10 and 20 days (p <0.05). Plasma
magnesium was lower in group C infants compared with group A (days 10 and 20, p
<0.001; day 30, p < 0.01) and lower in group C than in groups H and E at 10 days (p
<0.05). Group C infants were the only group in which plasma magnesium increased
with postnatal age (days 10 and 20 vs 40, p <0.001; 10 vs 30 days, p <0.05; 20 vs 30 days,
p <0.01).
Calcium and Phosphorus Balance: Effect ofMagnesium
Tables 4.7, 4.8 and 4.9 show the quantities of calcium, phosphorus amd magnesium
retained at each balance period of the studies. The effect of supplementing a low solute
formula with calcium and phosphorus (groups A to E) on the balance parameters of
these two elements at days 10, 20, 30 and 40 has been previously described (Giles et al,
1987). Increased gestational age (group H versus E) did not alter significantly the






A 2.36 (0.13) 2 .33 (0.10) 2 .31 (0.14) 2 . 38 (0.12)
B 2.41 (0.12) 2 . 37 (0.07) 2 .39 (0.07) 2 . 33 (0.12)
C 2.53 (0.17) 2.59 (0.28) 2.41 (0.23) 2.43 (0.15)
D 2.33 (0.28) 2 .42 (0.11) 2 . 34 (0.13) 2 . 30 (0.11)
E 2.38 (0.19) 2.40 (0.09) 2 . 39 (0.12) 2.43 (0.10)
F 2.40 (0.09) 2 .31 (0.14) 2 .31 (0.15) 2.30 (0.13)
G 2.47 (0.11) - -
H 2. 34 (0.19) - -
Values expressed as mean + -(SD)




A 2 . 50 (0.72) 2 .41 (0.41) 2 . 17 (0.20) 2 . 14 (0.29)
B 1.95 (0.31) 2 . 04 (0.32) 2.31 (0.61) 2 . 34 (0.40)
C 1.87 (0.50) 1.85 (0.61) 2 .21 (0.44) 2 . 39 (0.53)
D 2 . 61 (0.50) 2.46 (0.25) 2 . 51 (0.45) 2.61 (0.41)
E 2 . 47 (0.53) 2 . 66 (0.39) 2 .46 (0.32) 2 . 55 (0.29)
F 2.21 (0.13) 2 .29 (0.36) 2.36 (0.15) 2 .30 (0.37)
G 2.35 (0.27) - - -
H 2.42 (0.28) - - -
Values expressed as mean + -(SD)






A 0.96 (0.13) 0.91 (0.09) 0.92 (0.07) 0.86 (0.09)
B 0.81 (0.04) 0.84 (0.05) 0.85 (0.03) 0.86 (0.04)
C 0.76 (0.05) 0.82 (0.22) 0.82 (0.05) 0.85 (0.03)
D 0.82 (0.05) 0.80 (0.05) 0.86 (0.04) 0.82 (0.03)
E 0.89 (0.15) 0.84 (0.07) 0.86 (0.10) 0.87 (0.08)
F 0.83 (0.11) 0.83 (0.08) 0.88 (0.06) 0.87 (0.06)
G 0.81 (0.08) - - -
H 0.72 (0.10) - - -
Values expressed as mean +-(SD)






A 0.62 (0.34) 0. 68 (0.37) 0.86 (0.35) 1.20 (0.34)
B 1.79 (0.58) 1.70 (0.72) 2 . 02 (0.35) 2.52 (0.53)
C 2.42 (1.27) 2 .85 (1.12) 2.86 (0.93) 2.86 (0.83)
D 2.42 (1.21) 2 .37 (0.60) 2 . 11 (0.75) 2 . 34 (0.73)
E 2.30 (0.89) 2 . 57 (0.80) 2 . 68 (0.88) 3.01 (1.02)
F 2 . 64 (0.56) 3 . 00 (0.59) 2 .99 (0.80) 3.25 (0.84)
G 2 . 55 (0.77) - - -
H 2 . 61 (0.80) - - -
Values expressed as mean + -(SD)





A 24.8 (13.3) 27.2 (14.8) 34.4 (14.0) 48.0 (13.6)
B 71.6 (23.2) 68 . 0 (28.8) 80 . 8 (14.0) 100.8 (21.2)
C 96.8 (50.8) 114 . 0 (44.8) 114 . 4 (37.2) 114 .4 (33.2)
D 96.8 (48.4) 94 . 8 (24.0) 84 . 4 (30.0) 93 . 6 (29.2)
E 92.0 (35.6) 102 . 8 (32.0) 107.2 (35.2) 120.4 (40.8)
F 105.6 (22.4) 120. 0 (23.6) 119.6 (32.0) 130. 0 (33.6)
G 102.0 (30.8) - - -
H 104.4 (32.0) - - -
Values expressed as mean +-(SD)






A 1.01 (0.26) 1.13 (0.28) 1.20 (0.19) 1.40 (0.23)
B 1.49 (0.32) 1. 56 (0.32) 1. 53 (0.22) 1.73 (0.19)
C 1.85 (0.16) 1.68 (0.30) 1. 67 (0.25) 1.70 (0.24)
D 1.95 (0.45) 1.98 (0.34) 1.80 (0.31) 1.93 (0.33)
E 1.95 (0.73) 2 . 35 (0.57) 2 . 15 (0.32) 1.75 (0.44)
F 2.70 (0.30) 2.81 (0.39) 2 . 60 (0.27) 2 . 62 (0.17)
G 2.38 (0.42) - - -
H 2.21 (0.90) - - -
Values expressed as mean + -(SD)





A 30.4 (7.8) 33.8 (8.4) 35.9 (5.8) 41.9 (6.8)
B 44 . 6 (9.5) 46.8 (9.7) 46.0 (6.7) 52 . 0 (5.6)
C 55.6 (4.9) 50.3 (8.9) 50. 2 (7.5) 51. 0 (7.3)
D 58 . 6 (13.6) 59 . 4 (10.1) 54 . 0 (9.2) 58 . 0 (9.8)
E 58 . 4 (21.8) 70.4 (17.2) 64 . 5 (9.6) 52.4 (13.3)
F 81.1 (9.0) 84 . 3 (11.7) 77 . 9 (8.1) 78 . 6 (5.1)
G 71.5 (12.7) -
H 66. 2 (26.9) -
Values expressed as mean +-(SD)





A . 009 (.065) . 032 ( .086) . 081 ( .076) . 131 (.042)
B -.052 (.196) .057 (.098) . 058 (.038) . 158 (.068)
C -.012 (.105) . 084 (.088) . 043 (.061) .022 (•107)
D -.064 (.104) . 016 (.083) -.012 (.048) .045 (.078)
E -.066 (.090) -.099 (.143) -.015 (.120) . 005 (• H6)
F -.014 (.129) . 168 (.227) . 220 (.201) . 283 ( .241)
G .213 (.092) - - -
H . 036 (.125) - - -
Values expressed as mean +-(SD)
Table 4.9a: Magnesium retention at balance periods (mmol/kg/day)
Balance Period
1 2 3 4
Group
A 0. 216 (1.56) 0.768 (2.06) 1.944 (1.82) 3 . 144 (1.01)
B -1.248 (4.70) 1. 368 (2.35) 1.392 (0.91) 3.792 (1.63)
C -0.288 (2.52) 2 . 016 (2.11) 1. 032 (1.46) 0. 528 (2.57)
D -1.536 (2.50) 0.384 (1.99) -0.288 (1.15) 1. 080 (1.87)
E -1.584 (2.16) -2.376 (3.43) -0.36 (2.88) 0. 120 (2.78)
F -0.336 (3.10) 4 . 032 (5.49) 5.28 (4.82) 6.792 (5.78)
G 5. 110 (2.21)
H 0 .864 (3.00)
Values expressed as mean +-(SD)
Table 4.9b: Magnesium retention at balance periods (mg/kg/day)
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Comparison of two VLBW groups with similar calcium and phosphorus intake
(groups E and F; ) showed that magnesium supplementation (group F) had no
effect on any calcium balance measurement at days 10, 20, 30 and 40 (Table 4.7).
Similarly no changes were found in any aspect of phosphorus balance when groups
E and F were compared at day 10 (Table 4.8). However there were increases in
phosphorus retention (p <0.001) in group F vs E when the data from all the
balance periods were combined. No interaction with time was demonstrated.
Phosphorus retention decreased with time (p <0.05) at 10 vs 40 days and at 20 vs
40 days in both groups E and F.
In LBW infants there was no effect of magnesium supplementation on calcium and
phosphorus balance (group H vs G) at day 10 (Tables 4.7 and 4.8). Comparison of
groups of LBW and VLBW infants with and without magnesium supplementation
(group H vs E and group G vs F) showed no differences in calcium and phosphorus
balance.
Magnesium Balance: Effect ofMagnesium Intake
In VLBW infants comparison was made between groups E and F, in whom calcium
and phosphorus intakes were high and the same (Table 4.3) but in whom the
magnesium intake in group F was twice that of group E. Increasing the magnesium
intake (group F vs E) did not increase magnesium absorption (Figure 4.1) nor
retention (Figure 4.2) during the first balance period at day 10. However, group F
infants were in positive balance by day 20 and both absorption and retention
remained greater than in group E for the remainder of the study periods.
Comparison of LBW infants (group H vs G) showed that absorption (p <0.05) and
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Figure 4.1 Magnesium Absorption in Groups of VLBW and LBW Infants.
Values are expressed as bar graph with columns indicating mean
± SEM (mg/kg/day and mmol/kg/day) for each balance period
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Figure 4.2 Magnesium Absorption and Retention in Groups of VLBW and LBW Infants.
Dotted line from A to A' represents intrauterine magnesium accretion during third
trimester at 3.2mg/kg/day (Shaw, 1976; Ziegler et al, 1976).Values are expressed
as bar graph with columns indicating means (mg/kg/day and mmol/kg/day) of
absorption and retention for each balance period numbered 1,2,3 or 4.
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Magnesium Balance: Effect of Calcium and Phosphorus
The effects of calcium and phosphorus on magnesium balance were studied in
VLBW infants (groups A to E) in whom sequential increments were made in
calcium and then phosphorus intake but in whom magnesium intake was kept
constant (Table 4.3). Increments in calcium intake at constant magnesium and
phosphorus intakes (groups A to C) inhibited the postnatal trend of increased
magnesium absorption and retention; percentage magnesium retention differed
only in group B vs C at day 40. Sequential increments in phosphorus intake, with
constant magnesium intake and a high but constant calcium intake (groups C to E)
resulted in further reductions in magnesium absorption in all balance periods and
reduced magnesium retention at day 20. The inhibitory effects of calcium and
phosphorus on magnesium absorption, together with endogenous intestinal
magnesium losses, meant that some infants could be in negative balance for the
duration of the study period (Figure 4.2).
Magnesium Balance: Effect of Postnatal Age
In the VLBW groups, magnesium absorption increased with postnatal age (Figure
4.1) and magnesium retention increased in parallel (Figure 4.2), but this postnatal
age effect was significant only if formula calcium and phosphorus contents were
low (groups A and B). In the groups in which calcium and phosphorus content of
formulas were higher (groups C to E) magnesium absorption and consequently
retention were inhibited at all postnatal ages (Figure 4.2). The inhibitory influence
of calcium and phosphorus on magnesium absorption and retention could be
reversed if the magnesium content of the formula were increased (group F), with
restoration of significant postnatal increments in magnesium absorption (Figure
4.1) and retention (Figure 4.2). Increased postnatal magnesium retention was
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achieved in parallel with increased intestinal absorptive capacity, with perhaps a
small contribution through increased renal retention.
Magnesium Balance: Effect of Gestational Age
The LBW infants who had no supplemental magnesium retained more
magnesium than VLBW infants (group H vs E) at the same postnatal age, day 10
(Figure 4.2). This was also true for comparable groups who had magnesium
supplemented formulas (group G vs F), with differences in both absorption and
retention. However, percentage absorption was the same in LBW and VLBW
infants.
Urinary Magnesium Excretion
In the VLBW infants studied, urinary magnesium excretion (Table 4.10) increased
with increasing postnatal age (day 10 vs 40) in groups A and B (low phosphorus,
low magnesium, and low and intermediate calcium intake) and in group F (high
phosphorus, high magnesium and high calcium intake). However, in groups C, D
and E, urinary magnesium remained unchanged on days 10, 20, 30 and 40 (Table
4.10). In contrast, comparison of the LBW infants who received the same formulas
showed that urinary magnesium excretion increased (p <0.001) with magnesium
supplementation (group G vs H). The LBW infants who had no supplemental
magnesium (group H) had lower urinary magnesium excretion than in their less
mature counterparts (group E) at day 10, whereas LBW infants who had
supplemental magnesium (group G) had no difference in urinary magnesium
excretion when compared with VLBW infants (group F).
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Group Days 10-13 Days 20-23 Days 30-33 Days 40 -43
VLBW
A 0. 05 (0.03) 0. 07 (0.03) 0. 09 (0.03) 0. 08 (0. 02)
B 0. 04 (0.01) 0. 03 (0.02) 0. 07 (0.02) 0.07 (0. 03)
C 0. 06 (0.03) 0. 07 (0.05) 0.06 (0.02) 0.07 (0. 04)
D 0. 05 (0.02) 0. 03 (0.01) 0. 05 (0.02) 0. 04 (0. 01)
E 0. 06 (0.02) 0. 05 (0.02) 0. 05 (0.03) 0. 04 (0. 04)
F 0. 07 (0.03) 0.07 (0.02) 0.10 (0.03) 0.11 (0. 03)
LBW
G 0. 09 (0.03)
H 0. 03 (0.02) # . # . # . • #
Values expressed as mean +-(SD)
Table 4.10a: Urinaiy Magnesium Excretion (mmol/kg/day)
During Balance Periods
Group Days 10-13 Days 20-23 Days 30-33 Days 40-43
VLBW
A 1.17 (0.66) 1. 69 (0.66) 2 .11 (0.88) 1.96 (0.65)
B 0. 97 (0.33) 0.85 (0.45) 1. 52 (0.56) 1.78 (0.71)
C 1.39 (0.81) 1.51 (1.18) 1.37 (0.61) 1.69 (1.04)
D 1.12 (0.42) 0.87 (0.37) 1. 13 (0.42) 0.97 (0.34)
E 1.42 (0.48) 1.20 (0.68) 1.20 (0.83) 1.02 (0.93)
F 1.55 (0.75) 1.77 (0.68) 2 .28 (0.97) 2.45 (0.60)
LBW
G 2 . 08 (0.95) -
H 0. 67 (0.50) - -
Values expressed as mean + -(SD)




Sequential selection of cohorts is less ideal than a random assignment to groups
running concurrently because the possibility exists of introducing compounding
variables with time. Nevertheless staffing shortages in the neonatal unit during the
present study made sequential selection the only safe choice. No radical changes
of policy occurred in the unit throughout the period of the study, and clinical audit
showed no changes in the patterns of infections, nor in mortality rates of preterm
infants for the duration of the study.
Although previous studies in adult humans (Wilkinson, 1976) and the few available
in preterm infants have concluded that magnesium retention is unaffected by
calcium intake or retention (Moya & Domenech, 1982) the present study shows
that in the extreme preterm infants dietary balance of those elements does
influence magnesium retention and a significant deficiency can occur when
compared with intrauterine accretion rates (Greer & Tsang, 1985). Comparisons
of different studies at given gestational ages show wide variations in mean
accretion values: the limitations and assumptions made in whole body chemical
analysis of the fetus are many and have been critically reviewed (Fomon & Owen,
1962). Metabolic balance studies in general, for largely unexplained reasons have
a tendency to overestimate true retentions (Heroux & Peter, 1975). It can be
confidently asserted therefore that postnatal retention of magnesium in the
extreme preterm infants of the present study is significantly below intrauterine
accretion rates.
The most notable feature of the groups of extreme preterm infants who did not
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receive supplementary magnesium is their failure to attain intrauterine accretion
rates at almost any postnatal age. The exceptions to this are the 40 day balances in
groups A and B where the combined effects of maturation and a relatively low
calcium and phosphorus intake created conditions suitable for increased
absorption and retention. The interpretation of the present data need not be in
conflict with earlier reports in which adequate magnesium retentions were found,
as there are differences in the populations and conditions studied. Previous
studies of preterm infants have been based on post-conceptionally older infants,
with either greater gestational age (Okamoto et al, 1982; Moya & Domenech,
1982), or postnatal age (Day et al, 1975). In addition milks used in these studies
have lower phosphorus content (Okamoto et al, 1982) or lower calcium and
phosphorus content (Schanler et al, 1985; Atkinson et al, 1983) and sometimes
with a higher magnesium intake (Schanler et al, 1985; Atkinson et al, 1983) than
allowed by the present formulas.
In experimental animals, supplementing the diet with calcium or phosphorus
increases magnesium requirement, and magnesium deficiency is accentuated when
both calcium and phosphorus are augmented simultaneously rather than singly
(O'Dell, 1960). This is the pattern observed in the groups of extreme preterm
infants in the present study where calcium supplementation decreases magnesium
absorption and retention, with phosphorus having an additive effect. This pattern
is most obvious when magnesium absorption and retention in group C are
compared with groups D and E particularly at the earlier balance periods.
The present studies show both magnesium absorption and retention increased with
postnatal age. In addition comparison of more mature infants (groups G and H)
with less mature infants (groups E and F) may indicate that post-conceptional
maturity is an important factor in magnesium absorption and retention.
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In adults an important control of magnesium homeostasis is regulation of renal
excretion. Furthermore magnesium resorption increases in magnesium deficiency
(Quamme & Dirks, 1983). In the extreme preterm infants of the present study,
urinary magnesium losses were high even in states of negative balance suggesting
that renal conservation mechanisms for magnesium are immature or poorly
controlled. With increased postnatal age renal regulation appeared to improve,
and urinary magnesium losses increased only in groups A and B where magnesium
retention appeared adequate. In more mature infants (groups G and H) renal
conservation was greater than in their less mature counterparts (groups E and F)
even when absorbed magnesium was higher.
Diets high in magnesium content have not been found to alter calcium or
phosphorus balance if calcium and phosphorus are in adequate supply (Levine et
al, 1981). The effect of changing calcium and phosphorus contents is
unidirectional, with the effect being on magnesium. There is no reciprocal effect
of magnesium on calcium metabolism, and it may be that the reason is the large
difference in the molar concentrations of the two elements in various milk
formulas. In the VLBW infants studied, magnesium supplementation increased
phosphorus retention to intrauterine rates. The absorption of phosphorus was
unchanged suggesting an inter-related magnesium and phosphorus retention
perhaps in bone. Phosphorus absorption and retention percentages were higher in
group C compared with other groups unsupplemented with magnesium. The low
plasma phosphorus and extremely low urinary phosphorus losses, however, could
suggest that phosphorus intake was marginal at that calcium retention, but it does
not explain the lower plasma magnesium value at the early balance periods.
Perhaps an interrelationship exists between plasma levels of phosphorus and
magnesium as was seen in the studies of retention of these minerals.
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Percentage retentions of magnesium from whey based milks, similar in magnesium
content to our unsupplemented formulas are around 60% (Day et al, 1975). These
percentage retentions were not achieved at any age in our magnesium
unsupplemented groups although several individual infants did reach these rates.
In fact, absorption percentages were below these values in the majority of groups.
In adults magnesium percentage absorption is 25-65% and this wide range is
accounted for by individual variability (Levine & Coburn, 1984). Low magnesium
diet increases absorption to around 80% (Durlach & Durlach, 1984). Calcium and
vitamin D intake and dietary magnesium modify absorption (O'Dell, 1960; Levine
et al, 1981; Levine & Coburn, 1984) but these factors were constant within our
groups of infants. Surprisingly only the magnesium supplemented groups attained
high rates of percentage absorption of around 50% (groups F and G) and even
then not until 30 to 40 days after birth. Similar percentage absorptions have been
reported previously in preterm infants with high magnesium intakes (Moya &
Domenech, 1982; Schanler et al, 1985). Extreme preterm infants are therefore
vulnerable to magnesium deficiency states both through limited intestinal
absorption and limited renal capacity to conserve the magnesium that is absorbed.
Intracellular magnesium concentrations are generally well protected in deficiency
states (Levine & Coburn, 1984; Durlach & Durlach, 1984) and the predominant
features of inadequate supply are disordered bone growth, particularly in actively
growing animals (Schwartz & Reddi, 1979; Jones et al, 1980; Marie et al, 1983).
Magnesium deficiency in rats leads to demineralisation and lower rates of bone
formation and resorption (Durlach & Durlach, 1984; Schwartz & Reddi, 1979;
Jones et al, 1980; Marie et al, 1983; Clark & Belanger, 1967; Rayssiguier & Larvor,
1978) with diminished bone content, but with calcium remaining unchanged or
even increased (Marie et al, 1983). It remains speculative whether relative
magnesium deficiency in extreme preterm infants could lead to similar disordered
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bone mineralisation. It is nevertheless paradoxical that our efforts to increase
calcium and phosphorus retention to intrauterine rates and prevent rickets of
prematurity could leave the infant vulnerable to magnesium deficiency. This
emphasises the need for vigilance when formula compositions are modified.
In the absence of definable features of magnesium deficiency in preterm infants,
recommended intakes have been calculated with the use of a factorial approach,
the goal being to achieve postnatal retention that approximates in utero accretion.
Fetal calcium accretion exponentially rises in the last trimester, from 104-
125mg/kg/day (2.59-3.12mmol/kg/day) at 26 weeks to 119-151mg/kg/day (2.97-
3.77mmol/kg/day) at 36 weeks of gestational age (Shaw, 1976; Widdowson &
Dickerson, 1961; Forbes, 1976). Phosphorus accretion during this gestational range
is 60-85mg/kg/day (1.94-2.74mmol/kg/day), (Ziegler et al, 1976). Fetal
magnesium accretions are relatively constant in the last trimester, 3.16-
3.21mg/kg/day (0.131-0.134mmol/kg/day), (Clark & Belanger, 1967; Forbes,
1976). With milk formulas allowing calcium intake of 200-250mg/kg/day (5.00-
6.24mmol/kg/day) and phosphorus intake of 110-125mg/kg/day (3.55-
4.03mmol/kg/day), the bone mineral content of preterm infants increases at fetal
rates (Steichen et al, 1980) and retentions approach in utero accretions (Giles et
al, 1987). The American Academy of Pediatrics Committee on Nutrition (1985)
advised similar calcium and phosphorus intakes for preterm infants, with a
magnesium intake of lOmg/kg/day (0.4mmol/kg/day). Limited data on
magnesium metabolism were available at that time. Nevertheless the current
studies demonstrate that when calcium and phosphorus intakes meet retentions
equivalent to in utero accretions, magnesium deficits do occur with an intake of
lOmg/kg/day in VLBW infants. Greer and Tsang (1985) pointed out that
magnesium intake of 12 to 30mg/kg/day (0.49 to 1.23mmol/kg/day) could be
achieved as well as recommended calcium and phosphorus requirements, but only
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if high volume intakes were used to compensate for low mineral content of
formulas. To pursue the objective of achieving mineralisation equivalent to in
utero mineral accretion in small preterm infants, magnesium intake should be
nearer 20mg/kg/day (0.82mmol/kg/day) and formula composition modified
accordingly to achieve this at moderate volume intakes. It is paradoxical that
efforts to increase calcium and phosphorus retention to in utero rates, thus
perhaps preventing rickets of prematurity, could leave the infant vulnerable to
magnesium deficiency. This emphasises the need for vigilance when formula
compositions are modified.
Summary
Fifty-six male infants weighing less than 1500g at birth and less than 32 weeks
gestation were fed enterally from birth until day 47. Cohorts were given milk
formula varying in calcium, phosphorus and magnesium content: group A calcium
ll.Ommol/L, phosphorus ll.Ommol/L; group B calcium 21.2mmol/L, phosphorus
ll.Ommol/L; group C calcium 31.3mmol/L, phosphorus ll.Ommol/L; group D
calcium 31.3mmol/L, phosphorus 16.7mmol/L; group E and group F calcium
31.3mmol/L, phosphorus 21.3mmol/L. Milk formulas for groups A to E had a
magnesium content of 2.2mmol/L and in group F this as increased to 4.4mmol/L.
Three day balance studies were begun at days 10, 20, 30 and 40 for these groups.
Increasing calcium and phosphorus supplementation (groups A to E) decreased
magnesium absorption and retention. With an increased magnesium intake (group
F) absorption and retention of magnesium increased with postnatal age.
Increasing magnesium intake had no effect on any of the calcium balance
parameters but increased phosphorus absorption and retention. A further two
groups, G and H, of more mature infants (32-34 weeks gestation) were fed
formulas with compositions identical to those of groups F and E respectively.
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The last forty years have brought to the United Kingdom major contributions to
the health of the newborn infant: these include the rhesus isoimmunisation
programme, phototherapy, infection control in nurseries, detection of fetal genetic
disorders, rubella immunisation, and also neonatal screening for hypothyroidism
and phenylketonuria. The creation of neonatal intensive care units allowed
continuous neonatal monitoring, ventilator support, the ready use of arterial blood
gas tensions, and most recently the increasing use of replacement surfactants. In
developed countries the perinatal mortality has consistently fallen over the last
four decades, and now in the United Kingdom is less than 10 per 1,000 total
deliveries. The most dramatic component of these improved statistics has been
the survival of the very low birthweight infant. Closely parallelling these advances
in the care of the newborn has been the development of techniques of feeding low
birthweight infants, and the modification of breast milk and proprietary milks to
create fluids more suitable for the particular needs of the neonate.
The intrauterine environment provides the fetus with transplacental nutrients.
Preterm birth requires that the newborn be provided postnatally with nutrition
either by enteral or parenteral means (or both). Nevertheless agreement has still
not been reached over appropriate compositions of formulas, techniques of enteral
feeding, intervals between feeds, and the indications for and technical details of
the use of parenteral nutrition. While many paediatricians consider that the
postnatal growth of the preterm infant should approximate that which would have
occurred in utero (American Academy of Pediatrics Committee on Nutrition 1980;
Davies, 1981), others dispute that this is ideal or even possible. Is the pursuit of in
utero accretion rates appropriate for the nourishment of the growing preterm
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neonate? The improved survival rate of extremely low birthweight infants in the
last decade has presented new nutritional challenges in terms of quantity, quality,
method and frequency of delivery. Moreover, monitoring of adequacy of nutrition
is problematic because of lack of normative data for this abnormal population.
The Committee on Nutrition of the Preterm Infant, European Society of
Paediatric Gastroenterology and Nutrition (ESPGAN, 1987) has put forward
recommendations for the nutritional requirements of preterm infants, recognising
that often specific guidelines cannot be given because of the diversity of problems
which may confront the clinician looking after infants from 500g to 2500g. In
addition no recommendation is given for the nutritional management of the
preterm infant before enteral feeding has been fully established. The importance
of nutrition in the newborn period has been highlighted in a recent prospective,
randomised study which indicates that the early introduction of a nutrient-enriched
preterm formula may improve the developmental status at 18 months, involving
both motor and social maturity (Lucas et al, 1990). Furthermore protein fortified
human milk fed to low birthweight infants may provide better growth and an
improved immunological response as compared to those fed human milk alone
(Photopoulos et al, 1991). It may be necessary to set upper limits for any nutrient
in an infant formula (Wharton, 1989). It is essential to observe neonates for signs
of chemical toxicity and also to monitor biochemical parameters where
appropriate.
Can a nutritional deficiency at a critical time of rapid brain growth result in
permanent neurodevelopmental impairment? If so it is probable that this
principal will apply to both enteral and parenteral nutrition alike. Further work
needs to be done on the appropriate content of carbohydrate, amino-acids and
lipid used in total parenteral nutrition for the very low birthweight infant. Recent
studies (Lucas et al, 1988; Koh et al, 1988) imply that the plasma glucose levels of
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children should be maintained above 2.5mmol/L. Koh et al (1988) showed
abnormal sensory evoked potentials in children whose plasma glucose
concentration fell below 2.6mmol/L. Lucas et al (1988) demonstrated reduced
mental and motor development scores at 18 months corrected age in preterm
infants who had experienced "moderate hypoglycaemia" for a number of days in
the newborn period: if hypoglycaemia was recorded on five or more separate days
there was an increased incidence of subsequent cerebral palsy or developmental
delay. In caring for the low birthweight infant who requires intravenous fluids, the
clinician may therefore choose an appropriate concentration of dextrose to fulfil
this suggested need.
When pursuing an ideal amino-acid solution for the very low birthweight infant, is
it valid to measure serially the levels of plasma amino-acids of the parenterally fed
neonate, and to use as a perfect standard the plasma amino-acid levels of a healthy
newborn infant with similar postmenstrual age? Plasma amino-acid
concentrations of the breast-fed infant have been documented (Pohlandt, 1978),
and there is little difference in the amino-acid pattern seen in formula-fed low
birthweight infants (Ventura & Brooke, 1987). It is not clear, however, that the
preterm infant will receive the most appropriate amino-acid intake if the only
measure is plasma levels, since these may not reflect protein accretion in other
tissues, in particular the central nervous system. Clark and coworkers (1989) have
documented 10th, 50th and 90th centiles for individual plasma amino-acid levels in
109 sick preterm infants fed an intravenous regimen which included Vamin 9
Glucose. They hypothesised that immaturity of a hepatic enzyme in sick preterm
infants may result in hypertyrosinaemia which has been documented with
parenteral feeding (Clark et al, 1989). Nevertheless Mcintosh and Mitchell (1990)
have demonstrated that an intravenous amino-acid preparation can maintain the
plasma aminogram of parenterally fed newborn infants within a reference range
obtained from cord blood samples. Further work needs to be done to show that the
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lower phenylalanine levels achieved by this amino-acid preparation can bring
about an improved neurodevelopmental outcome for such preterm infants.
Controversy also surrounds the available methods of lipid infusion and their
associated morbidity. Side effects of intravenous lipid solutions include fever,
respiratory distress, cholestatic jaundice, decreased platelet adhesiveness and
hyperlipidaemia. Anxieties have also been expressed (Levene et al, 1980;
Friedman et al, 1978) about the identification of lipid deposits in pulmonary
capillaries of newborn infants receiving lipid infusates. It may be that up to
3g/kg/day of intravenous lipid is required to achieve rapid growth of the preterm
infant. Although clinicians may start at lower rates such as 0.5g/kg/day and then
increase (Wells et al, 1989) there is little evidence that this is advantageous to the
very low birthweight infant. Brans et al (1988) recommend 24 hour infusions of
O.llg/kg/hour to avoid hyperlipidaemia, yet Wells and coworkers (1989) delivered
3g/kg/day over 20 hours (0.15g/kg/hour) without causing elevated total lipid
levels in their population of very low birthweight infants. Concerns have been
expressed about the possible role of lipid infusions in causation of morbidity of
sick preterm infants, including a possible causal association with
bronchopulmonary dysplasia and retinopathy of prematurity (Hammerman &
Aramburo, 1988): it is certainly conceivable that elevated plasma thromboxane
levels could cause pulmonary and retinal vasoconstriction which might contribute
to evolving morbidity in lung and eye. Dhanireddy and coworkers (1981) have
warned that infants of 27 weeks gestation or less may be deficient in lipoprotein
lipase and therefore are less able to tolerate intravenous lipids. Even the most
appropriate concentration of lipid infusion is not yet clear. 10% intralipid is
widely used as a source of intravenous fats for the parenterally fed newborn infant,
but it may be that 10% intralipid causes hyperlipidaemia due to a rise in plasma low
density lipoproteins and lipoprotein-X (Tashiro et al, 1989). Plasma cholesterol
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levels have also been shown to rise higher in low birthweight infants whose source
of lipid is 10% compared to similar infants fed with similar total quantities
(g/kg/hour) but in whom 20% intralipid was the chosen infusate (Haumont et al,
1989), this effect probably being mediated by the elevated phospholipid intakes
associated with 10% intralipid.
In preterm infants "physiological ileus" may occur due to immature intestinal
motility (Dunn, 1963) Although the human intestine is "histologically mature" by
22 weeks gestation (Hart & Mir, 1971) intolerance of feeds is well recognised in
extreme preterm infants. This implies that there remains a functional immaturity,
perhaps of gut motor control. Knowledge of the functional development of the
intestine has increased in the last decade. Bernbaum et al (1983) showed that non-
nutritive sucking increases enteral food tolerance, via a presumed vagally-
mediated reflex. Gastric emptying in preterm infants is often incomplete, and is
known to decrease as the energy density of the milk increases (Siegel, 1983).
Manometric studies have shown that pressures generated during gastric
contraction increase with advancing gestational age (Bisset et al, 1986). The
response of the small intestine to food is a function of the volume, the nutritional
density and the sensitivity of the gut to these stimuli (Bisset, 1991). The
postconceptional age of the preterm infant is not a major determinant (Bisset et al,
1989), but the early introduction of enteral feeds is likely to stimulate the intestinal
motor responses (Bisset et al, 1989). Intestinal milk also increases gut hormone
concentrations (Lucas et al, 1986) and brush border digestive function (Hughes &
Dowling, 1980).
Nasoduodenal feeding had previously established itself as being safer than total
parenteral nutrition for a similar population in our institution (Glass et al, 1984).
Since data on the potential dangers of nasogastric feeding were inconclusive, it was
appropriate to compare nasogastric feeding with the then established routine of
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favouring the nasoduodenal route. The latter, which was a more time-consuming
method, and apparently stressful for the infants, offered no identifiable advantages
in our study (Laing et al, 1986). Subsequently other studies have suggested the
benefits of orogastric feeding in keeping the nares free, thus decreasing upper
airway resistance to breathing, and reducing the occurrence of apnoea (Van
Someren et al, 1984). Although an orthodontic plate used in these studies proved
successful in holding the orogastric tube stable, simple taping of the orogastric
tube to the upper lip may be equally effective (Van Someren, 1991, personal
communication). Salivation loosening the tape, and potential displacement of an
orogastric tube by the mobility of the tongue have not proved to be a significant
problem in practice.
Although gastric feeding has now established itself as the favoured technique for
feeding the low birthweight infant, the recommended volume and frequency of
feeds are still controversial. In the present study the fluid regimens were based on
50ml/kg/day for the first full day followed by increments of 25ml/kg/day each day
until 150ml/kg/day on day 5; thereafter volumes were increased according to
clinical need and toleration. With improved survival of infants born before 28
weeks gestation and weighing less than lOOOg at birth, account must be taken of
the very high fluid losses from the skin of these extremely low birthweight infants
in the early days of life even when intensive care is given in an incubator with
optimal humidification of the infant's environment. In this group it is appropriate
to take into account estimated insensible water loss, which may be 65ml/kg/24
hours (Tuck, 1986), although this figure may vary according to environmental
conditions from 2-6ml/kg/hour (Shaw, 1988). In clinical practice it may be
advisable to calculate the optimal fluid intake at 6-hourly intervals initially, based
on estimated insensible fluid loss, change in body weight, measured urinary output,
plasma sodium concentration and urinary specific gravity.
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The approach to the delivery of gastric fluid to the very low birthweight infant may
also be an empirical one. It is common practice to empty the stomach of its
contents 3-hourly or 4-hourly to check the adequacy of transpyloric passage of
milk, thus reducing the chances of gastro-oesophageal regurgitation and potential
milk inhalation. The true 24-hour intake of milk administered must then be
calculated based on whether the volume of semi-digested milk returned to the
stomach influences the amount of additional milk delivered thereafter. It has not
been firmly established for an individual weight group or gestational age which has
the highest probability of volume tolerance - continuous gastric feedings, or hourly,
2-hourly, 3-hourly or 4-hourly intakes. Healthy preterm infants receiving milk by
continuous gastric infusion have a different endocrine profile to those receiving
boluses of milk (Aynsley-Green, 1982). Postprandial gut activity is dependent in
part on the volume of feed delivered (Bisset et al, 1989), and is associated with the
release of intestinal polypeptide hormones including gastrin, cholecystokinin
(Wingate et al, 1978), and peptide YY (Adrian et al, 1986). It is tempting to infer
that bolus feeding is therefore more "physiological" for the preterm neonate, but
there has been no empirical observation that, at a given weight-group, the very low
birthweight infant establishes a superior nutritional status by intermittent feedings.
It is clear however that early enteral feeds stimulate a postprandial intestinal
response, and that total parenteral nutrition delays the development of intestinal
activity (Lucas et al, 1980). More recent work suggests that even very small
volumes of feed may stimulate intestinal hormones (Lucas et al, 1986).
Milks available for feeding low birthweight infants include preterm breast milk
from the mother, milk donated by a mother at term, banked donor milk,
supplemented human milk, adapted cow's milk, soy milk and specially developed
proprietary milks modified for the perceived needs of the preterm infant. Human
breast milk may be deficient in protein, calories, sodium, calcium, phosphorus,
88
magnesium, iron and perhaps vitamins B2, B6, C, D, E, K and folic acid. Preterm
infants increase in weight and length faster if fed human mature breast milk
supplemented with human milk protein (protein intake 3.2g/kg/day) than if fed
breast milk alone (protein intake 1.8g/kg/day), (Ronholm et al, 1986).
The calcium content of a fetus rises from 2.4g (60mmol) in a fetus weighing 500g
to 30.4g (760mmol) in a fetus weighing 3.5kg, representing a rate of accumulation
of approximately 3.0 to 3.25mmol/kg/day (Shaw, 1973; Ziegler, 1976). Fetal
phosphorus content rises from 1.5g (48mmol) in a fetus of 500g to 16.7g
(539mmol) in a fetus of 3.5kg, representing an accretion rate of 2.1-
2.4mmol/kg/day. It has been estimated that 0.6mmol/kg/day of phosphorus is
laid down for soft tissue growth and the rest is deposited in bone (Shaw, 1988).
Breast milk and most currently available proprietary formulae have a lower
calcium and phosphorus content than would be sufficient to imitate in utero
accretion rates. Because proprietary milks still show variation in mineral content,
the present studies were designed to advance knowledge of the appropriate
contents of calcium, phosphorus and magnesium in proprietary milks, and to
elucidate the effects that varying the concentration of one might have on the
absorption or retention of others.
Unlike phosphorus, calcium is not well absorbed from formula milks, although
higher bioavailability in breast milk allows up to 70% calcium absorption provided
that phosphorus and vitamin D content are adequate (Senterre & Salle, 1982).
Calcium absorption from low solute milks may vary from 30% to 60%, of which
80% to 95% of absorbed calcium may be retained (Shaw, 1976). It has also been
established that calcium absorption increases with gestational age
(Tantibhedhyangkul and Hashim, 1978; Okamoto et al, 1982; Shaw, 1976) and with
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gestational age (Tantibhedhyangkul and Hashim, 1978; Okamoto et al, 1982;
Shaw, 1976).
Calcium accretion rates increase from 130mg/kg/day (3.3mmol/kg/day) at 28
weeks gestation to 150-155mg/kg/day (3.8-3.9mmol/kg/day) at term (Shaw, 1976).
The calcium intake of the male infants was estimated by balance studies and
published subsequently (Giles et al, 1987): these studies showed a rise from
85mg/kg/day (unsupplemented group A) to above 230mg/kg/day for groups C, D,
and E. Increments in calcium intake produced increases in both calcium net
absorption and retention at all ages: calcium retention was maximal in group C at
20 days with a mean retention of greater than 130mg/kg/24 hours. The current
studies showed that calcium supplementation of a low solute milk may prevent the
radiological changes of rickets in preterm infants (Laing et al, 1985). Nevertheless
these groups supplemented with calcium alone still had elevated alkaline
phosphatase activity.
Phosphorus depletion occurs particularly in preterm infants who are fed
exclusively on breast milk (Rowe & Carey, 1987). If the phosphorus intake is
insufficient to provide for the soft tissues, approximately 0.6mmol/kg/day, as well
as maintaining plasma phosphate levels, then the changes of rickets are seen at the
growing ends of long bones. In this situation, Rowe and Carey (1987) describe
hypophosphataemia, high plasma alkaline phosphatase activity, high urinary
calcium and low urinary phosphate. Phosphate supplements given to such infants
can improve calcium retention (Senterre et al, 1983) but do not eliminate
osteopenia. In our studies of low birthweight infants fed a supplemented
proprietary milk, phosphorus intakes were measured in male infants and published
later (Giles et al, 1987). Phosphorus absorption was 90-96% by all infants
irrespective of calcium intake.
Phosphorus retention rose to approximately 60mg/kg/day in Group D as reported
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by Giles et al (1987). This figure represents the lower level of in utero accretion
rates quoted by Ziegler et al (1976). Renal retention of phosphorus can be almost
complete (Carey et al, 1985) but phosphorus excretion may increase if phosphorus
intake is excessive (Carey et al, 1985).
Nevertheless, pursuing intrauterine accretion rates of individual minerals may not
be entirely valid. The postnatal infant differs in many ways from the fetus of the
same post-menstrual age. Furthermore there are limitations to the accuracy and
validity of chemical analyses of the fetus (Greer & Tsang, 1985). Metabolic
balance studies also are subject to inaccuracy, with a tendency to everestimate true
retention (Fomon & Owen, 1962; Hegsted, 1976). Bhatia and Fomon (1983)
highlighted the difficulty of sedimentation of added mineral, and this proves to be
a problem especially with the use of calcium lactate which is insoluble. In the
current studies, however, the products were prepared fresh in the Neonatal Unit
on a daily basis, and solubility studies confirmed the concentrations of mineral
received by the infants. During our balance studies, errors due to sedimentation
could have been compounded by spillages, possets or vomits, and so all intake
residues were carefully collected and analysed. It must be recognised however that
the need for daily preparation of fresh supplemented milks makes this method
commercially unattractive, and certainly labour intensive for a busy neonatal
referral centre.
Despite the above caveats, the mineral intake of the infants approached in utero
accretion rates during the current studies. Most important of all was achieving the
goal of avoiding overt radiological and biochemical bone disease in the groups
supplemented with both calcium and phosphorus. The current studies further
suggest that bone disease can largely be avoided, as in group B, at retentions of
calcium and phosphorus less than in utero accretion rates. This is important
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because it has previously been shown that excess dietary calcium may result in
supermineralisation (Day et al, 1975) and fat malabsorption (Chappell et al, 1986).
The further addition of phosphorus (in group D) allowed the mean alkaline
phosphatase activity to remain within the normative range until the last week of
the study period. Nevertheless until further examination of the metabolism of the
preterm neonate has been carried out, it may be desirable to supplement the milk
supply with just enough calcium and phosphorus to avoid bone disease. Our
principal therapeutic aim throughout the mineral supplementation studies was to
eliminate rickets of prematurity. No method of assessment of bone mineralisation
is yet perfect. Radiological methods may lack precision, and photonabsorptiometry
has been recommended as a more reliable technique. But photonabsorptiometry is
not widely available and may not establish itself as a routine clinical tool.
Furthermore it provides only an estimate of concentration, and does not give an
assessment of skeleton size nor yet total bone mineral content. The subject of
assessment of bone mineralisation in infants has recently been extensively
reviewed (Filer, 1988). Alkaline phosphatase activity was also used as a possible
measure of rickets, a normative range having previously been established in our
institution (Glass et al, 1982). Recent studies (Lucas et al, 1989) have lent further
credence to the usefulness of alkaline phosphatase activity as a biochemical
marker of osteopenia: high peak alkaline phosphatase activity correlated in
preterm infants with a slower growth rate in the neonatal period, and to a
significant reduction in body length at 9 and 18 months post-term.
During our studies of mineral supplementation, all the infants received 460i.u.
daily of vitamin D2 in addition to the proprietary formula which contained vitamin
D3 420i.u./litre. The total daily intake of vitamin D in our studies was
approximately 500 to 600i.u. The ideal vitamin D intake for preterm infants is not
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known (Brooke, 1983). Rickets may occur in very low birthweight infants even
with normal or high serum 25-hydroxycholecalciferol levels (Mcintosh et al, 1982;
Chesney et al, 1981; Steichen et al, 1981). Hydroxylation of vitamin D in both liver
and kidney are adequate (Chesney et al, 1981; Mcintosh et al, 1982; Steichen et al,
1981) and the preterm gut is responsive to l,25dihydroxylation (Senterre & Salle,
1982). It is not apparent how the ESPGAN (1987) committee arrived at
recommendations of 800-1600i.u./day.
It is clear that the content of a mineral in milk may influence the absorption and
metabolism of another mineral. In vitamin D deficient rats, high dietary
magnesium resulted in decreased intestinal absorption of calcium (Levine et al,
1981). Marie et al (1983) showed that increased magnesium supplementation of
dietary intake of rats caused increased serum calcium and phosphorus, probably
due to increased bone mobilisation of minerals. Renal excretion is also changed.
Magnesium deficiency may cause hypocalciuria and hyperphosphaturia (Durlach
& Durlach, 1984) and Giles et al (1987) showed that when calcium intake is
"sufficient" in low birthweight infants, urinary excretion of phosphate increases as
phosphorus intake rises. In the current studies increasing supplementation of
calcium and phosphorus resulted in decreased magnesium absorption from milk,
producing magnesium retention lower than in utero accretion rates. Nevertheless
increasing the magnesium intake improved retention, especially in the more
mature infants and especially those older in postnatal days.
Very low birthweight infants have limited intestinal absorption and renal retention
of magnesium. The calcium and phosphorus supplementation of our milks may
have produced a total body deficiency of magnesium. Durlach and Durlach (1984)
identified the possibility that magnesium deficiency might result in decreased
plasma magnesium concentration, decreased plasma calcium concentration and
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decreased intracellular potassium concentration. Hypophosphataemia and
hypokalemia may also be seen. In our studies the plasma calcium did not change
significantly, and the phosphate levels also remained within the normal range. We
did not study urinary hydroxyproline, which, as shown by Rayssiguier and Larvor
(1978), may decrease with magnesium deficiency in rats, implying decreased bone
catabolism, probably due to decreased bone magnesium content. In the present
studies, even when both calcium and phosphorus intakes were increased (group D)
no clinical nor biochemical syndrome was identified which implied adverse effects
of total body magnesium deficiency. Neither magnesium deficiency nor
magnesium overload has been described in preterm infants, and the ESPGAN
(1987) should not exceed 12mg/100kcal. Nevertheless magnesium deficiency in
rats has resulted in bone demineralisation (Durlach & Durlach, 1984; Schwartz &
Reddi, 1979; Jones et al, 1980; Marie et al, 1983) and must serve as a reminder
that efforts to increase the calcium and phosphorus contents of milk could
theoretically produce a bone disorder secondary to magnesium deficiency.
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Composition of Pooled Human Breast Milk
(Department of Health and Social Security, 1980)
and
SMA Gold Cap Formula
(Wyeth Laboratories)
Human Breast Milk SMA Gold Cap
Energy 70kcal 65kcal
Protein 1. 3g 1. 5g
Fat 4 . 2g 3 . 6g
Carbohydrate 7. Og 7. 2g
Sodium 15mg (0.65mmol) 15mg (0.65mmol)
Potassium 60mg (1.5mmol) 56mg (1.4mmol)
Calcium 35mg (0.88mmol) 44mg (l.lmmol)
Phosphorus 15mg (0.48mmol) 33mg (l.lmmol)
Magnesium 2.8mg (0.12mmol) 5.3mg (0.22mmol)
Chloride 43mg (1.2mmol) 40mg (l.lmmol)
Iron 7 6ug 675ug
Copper 39ug 48ug
Zinc 295ug 3 70ug





Ketovite Liquid (Paines & Byrne)
Vitamin A 2500 i.u.
Vitamin D 400 i.u.
Choline chloride 150mg
Cyanocobalamin 12.5ug
























Preparation of Formulas with Varying Calcium and Phosphorus Content
Group A B C D E
SMA Gold Cap
Concentrate
50 50 50 50 50
Distilled Water 47 . 5 43 42 41.5 41.5
Sodium Chloride 0.8 0 . 8 - - -
Sodium Bicarbonate 1.2 1.2 2 . 0 2 . 0 1.5
Sodium phosphate - - - - 0.5
Potassium chloride 0.5 0.5 - - -
Potassium phosphate - - - 0.5 0.5
Calcium gluconate - 4 . 5 5.0 5.0 5.0
Calcium chloride - - 1.0 1.0 1.0
Volume ofMilk and Additives (ml per 100ml of final product)
S.M.A. Gold Cap concentrated liquid
Sodium chloride 5.84% wt/vol
Sodium bicarbonate 8.3% wt/vol
Calcium gluconate 10% wt/vol
Calcium chloride 13.4% wt/vol
Potassium phosphate 17.42% wt/vol
Potassium chloride 15% wt/vol
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APPENDIX 4
Analysis of Formulas with Varying Calcium and Phosphorus Content
Characteristics of Milk Formulas
Group Calcium content Phosphorus content
(mg/dL) (mmol/L) (mg/dL) (mmol/L)
A 44 . 5 11.0 33 11.0
B 84 . 5 21.2 33 11. 0
C 124.5 31.3 33 11. 0
D 124 . 5 31.3 50 16.7
E 124.5 31.3 64 21.3
F 124.5 31.3 64 21.3
G 124 . 5 31.3 64 21.3
H 124.5 31.3 64 21.3
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APPENDIX 5
Normative Data for Plasma Alkaline Phosphatase Activities







26+27 319 (142) 13
28+29 292 (86) 26
30+31 281 (84) 46
32 +33 254 (72) 53
34 +35 236 (62) 103
36 207 (60) 48
38-41 164 (68) 60
Values of alkaline phosphatase activity are expressed as mean+-(SD)
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